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Tiivistelmä 
Tutkimuksen tausta ja tavoitteet: Lantionpohjan ja virtsaputken kudosvaurioiden korjaami-
seen ei ole vielä olemassa täysin optimaalista korjausmenetelmää tai -materiaalia. Lantionpoh-
jan laskeuma on hyvin yleinen ongelma naisilla. Ensisijaisesti laskeumat korjataan potilaan 
omilla kudoksilla, mutta näihin korjausmenetelmiin liittyy jopa 30 %:n riski laskeuman uusiu-
tumiseen. Osa uusiutuneista laskeumista korjataan tavallisimmin sulamattomalla polypropy-
leeni -verkolla, johon liittyy komplikaatioita, kuten verkon eroosiota ja lantion alueen kipuja. 
Myös virtsaputken rakenteellisten poikkeamien, kuten kuroumien ja hypospadian, korjaami-
seen nykyisillä menetelmillä liittyy useita komplikaatioita, kuten uusien kuroumien ja fistelien 
muodostuminen. Tässä työssä tutkittiin urologisiin ja gynekologisiin sovellutuksiin uutta kor-
jausmateriaalia poly(L-laktidi-ko-ε-kaprolaktoni) -tukirakennetta, johon on lisätty tiettyä as-
korbiinihapon johdannaista (PLCLas). Tavoitteena oli määrittää askorbiinihapon johdannaisen 
(AAD) vaikutus ihmisen vaginan stroomasoluihin, rasvan kantasoluihin sekä uroteelisoluihin 
yksisoluviljelmissä sekä rasvan kantasolujen ja uroteelisolujen yhteisviljelmässä.  
Tutkimusmenetelmät: Vaginan stroomasoluja viljeltiin yksisoluviljelmässä PLCL kalvoilla, 
ja rasvan kantasoluja ja uroteelisoluja ylikriittisellä hiilidioksidilla huokoistetuilla PLCL tuki-
rakenteilla yksisolu- sekä yhteisviljelmissä 1, 7, ja/tai 14 päivän ajan. Solujen elinkyky ja mor-
fologia määritettiin Live/Dead® analyysillä sekä pyyhkäisyelektronimikroskoopilla. Solujen 
jakaantuminen määritettiin kvantitatiivisesti CyQUANT® analyysillä, ja tuotetun kollageenin 
kokonaismäärä Sircol™ analyysillä. Tiettyjen proteiinien ilmentymistä tutkittiin immunovär-
jäyksillä, ja valikoitujen geenien ilmenemistä reaaliaikaisella kvantitatiivisella polymeraasiket-
jureaktiolla. 
Tutkimustulokset: Kaikki solutyypit pysyivät elinkykyisinä tutkituilla biomateriaaleilla. 
Stroomasolut säilyttivät myofibroblasti -fenotyypinsä ja rasvan kantasolut kykynsä erilaistua 
lihassolujen suuntaan sekä PLCLas että PLCL tukirakenteilla, myöskin uroteelisolujen feno-
tyyppi säilyi molemmilla biomateriaaleilla. AAD lisäsi merkitsevästi vaginan stroomasolujen 
ja rasvan kantasolujen jakaantumista sekä kollageenin tuotantoa. Uroteelisoluissa vaste oli puo-
lestaan vastakkainen, ja solumäärä ja kollageenin tuotanto vähenivät. AAD paransi rasvan kan-
tasolujen elinkykyä yhteisviljelmässä. Lisäksi sekä rasvan kantasolut että uroteelisolut säilytti-
vät fenotyyppinsä yhteisviljelmässä. 
Johtopäätökset: AAD lisää stroomasolujen ja rasvan kantasolujen kollageenin tuotantoa ja ja-
kaantumista, mutta uroteelisoluissa vastaavaa vaikutusta ei nähty. Uroteelisolut ja rasvan 
kantasolut säilyivät elinkykyisinä yhteisviljelmässä, mutta yhteisviljelmän medium vaatii vielä 
optimointia. Saatujen tulosten perusteella PLCLas tukirakenne vaikuttaa potentiaaliselta 
materiaalilta urologisiin ja gynekologisiin sovelluksiin. 
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Abstract 
Background and aims: Repair of pelvic floor and urethral defects both currently lack the ideal 
repair methods and materials. Pelvic organ prolapse (POP) is a very common disorder affecting 
numerous women. Current repair methods for POP are insufficient and 30 % of primary repair 
surgeries lead to relapse and ultimately may need repair with nonabsorbable polypropylene 
surgical mesh with substantially high risk of complications as mesh erosion and pelvic pain. 
Repair of urethral defects, such as strictures and hypospadia, are also prone to complications 
with the currently available methods and often lead to formation of strictures or fistulas, for 
example. Aim of this study was to determine the cellular effect of ascorbic acid derivate (AAD) 
embedded in biodegradable poly(L-lactide-co--caprolactone) PLCL scaffolds, when 
compared to plain PLCL scaffolds in human vaginal stromal cell (hVSC), adipose derived stem 
cell (hASC) and urothelial cell (hUC) monocultures and hUC/hASC co-culture. 
Methods:  PLCL membranes with or without embedded AAD were studied with hVSCs for 
pelvic floor fascia regeneration. For regeneration of urothelial defects, hUC and hASC 
monocultures and hUC/hASC co-culture were performed on plain or AAD embedded 3D 
scPLCL scaffolds. Cellular effect of AAD in PLCL scaffolds was analyzed with variety of 
analyses in time points of d1, d7 and d14; Cell viability and morphology was determined with 
Live/Dead® assay and scanning electron microscope imaging. Cell proliferation was quantified 
with CyQUANT® assay and collagen production with Sircol™ assay. Expression of specific 
markers was visualized with immunocytochemistry, and gene expression of specific genes was 
quantified with real-time polymerase chain reaction. 
Results: Cells remained viable on all biomaterials. AAD significantly increased the collagen 
production and cell proliferation of hVSCs and hASCs, whereas decreased them in hUCs. 
Human VSCs synthetized collagen more rapidly on PLCL membrane with AAD and 
maintained myofibroblastic phenotype on membranous PLCL with or without AAD. In hASC 
monoculture on 3D PLCL with AAD, the cells proliferated rapidly, covering the scaffold with 
dense cell sheet. On plain PLCL scaffolds both hVSCs and hASCs formed cell clusters, not 
spreading on the material surface. Human ASCs maintained their myogenic potential and hUCs 
their phenotype in 3D PLCL scaffolds with and without AAD. Further, AAD seemed to enhance 
the viability of hASC in hUC/hASC co-culture. 
Conclusion: AAD in PLCL scaffolds enhance hVSC and hASC proliferation, whereas such 
benefit in hUCs was not seen. Increased collagen production and hVSC proliferation would 
enhance regeneration of neofascia and thus be very beneficial for pelvic floor applications. Cells 
in hUC/hASC co-culture remained viable with added AAD, and thus this design could be 
optimized in further studies to be used in regenerating functional urothelium and smooth muscle 
layers in urethral tissue. In all, PLCL scaffolds with embedded AAD seem promising for 
urological and gynaecological tissue engineering applications.  
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1 INTRODUCTION 
Tissue engineering has become a promising novel method for treating urological and 
gynaecological defects. Urethral defects are rather common and mainly caused by traumas, 
infections, iatrogenic causes or due to congenital disorders such as hypospadias (Yamzon et al., 
2008). The reconstruction of urological defects is highly challenging. Typically, small urethral 
defects are repaired with patients’ own genital tissue, yet this is insufficient for larger defects. 
Reconstruction of larger urethral defects requires additional autologous or allogenic non-
urologic grafts, which brings the challenges to even greater level. Further, the autologous donor 
sites are very limited. The most frequently used nonurologic tissue is oral buccal mucosa. 
Additionally, bladder acellular matrix (BAMG) and small intestinal submucosa (SIS) have been 
studied for urethral reconstruction. Yet, the nonurologic grafts lack the proper functional 
properties of urethra and often lead to complications such as strictures or formation of fistulas. 
(de Kemp et al., 2015; Garriboli et al., 2014; Maya et al., 2010; C. Zhang et al., 2014) Due to 
major difficulties and challenges of urethral repair, developing a new treatment method, such 
as tissue engineering based approach, is important. Cell-seeded scaffolds such as poly-lactic 
acid (PLA), poly(lactic-co-glycolic acid) (PLGA) and poly(L-lactide-co-caprolactone (PLCL) 
have been studied for urethral and bladder reconstruction with potential results (Atala et al., 
2006; de Kemp et al., 2015; Garriboli et al., 2014).  
In addition to urethral defects, developing new treatment methods for pelvic organ prolapse 
(POP) was the other focus of this study. POP is a highly common problem affecting a large 
number, even up to 50 % (FDA, 2011), of women. It is defined as descent of the anterior and/or 
posterior vaginal wall, the uterus and/or the vaginal apex, due to weakened support of the fascia 
and pelvic muscle floor. The POP is primarily repaired with patient’s own fascia (Osborn et al., 
2013) yet the recurrence level is up to 30 % (Barber & Maher, 2013; Osborn et al., 2013). If the 
primary surgery fails and need reoperation, the recurrent prolapse is usually treated with 
synthetic non-absorbable polypropylene mesh. However, these mesh operations are susceptible 
to complications such as pain, mesh erosion or contraction and sexual dysfunction. (Osborn et 
al., 2013; Roman et al., 2015) In fact, in 2011 the U.S. Food and Drug Administration (FDA) 
has classified the surgical mesh to have a risk classification of Class III: the highest possible 
risk class (FDA, 2011). Therefore, as current methods are insufficient, developing novel 
repairing methods is crucial. Again, tissue engineered scaffold could be a one possible answer 
for this challenge.  
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This masters project studies specific ascorbic acid derivate (AAD) embedded in poly(L-lactide-
co-ε-caprolactone) (PLCL) membranes and three-dimensional (3D) scaffolds for urological and 
gynaecological applications. PLCL scaffolds have shown promising results in soft tissue 
applications such as urothelial, vascular and neural tissue engineering (Laurent et al., 2018; 
Prabhakaran et al., 2009; Sartoneva et al., 2011; Shafiq et al., 2015). The aim of this study was 
to determine the effect of added specific salt to cell function in human vaginal stromal cells 
(hVSCs), human urothelial cells (hUCs) and human adipose derived stem cells (hASC). The 
induced cellular effect of added specific ascorbic acid derivate was compared to cells cultured 
on plain PLCL scaffolds. AAD is hypothesized to enhance formation of extra cellular matrix 
and collagen, and thus contribute to repair of soft tissue and guide the differentiation of hASC 
towards smooth muscle cells (SMCs). The 3D PLCL-scaffold could provide applicable tissue 
engineered graft for urethral defects to regenerate defected urothelium, smooth muscle and soft 
tissue. Membranous PLCL-scaffold in turn could provide support and regenerate the natural 
pelvic fascia support system in defected pelvic floor.  
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2 REVIEW OF THE LITERATURE 
2.1 Anatomy and histology of urinary tract 
The urinary tract conveys urine outside of the body and consists of kidneys, ureters, urinary 
bladder and urethra. Renal pelvis collects urine from kidney to be carried to urinary bladder 
along ureter. Urine is stored in urinary bladder and excreted from the body through urethra. 
(Drake et al., 2015) Organs in urinary system are presented in Figure 1.  
 
Figure 1 Organs in urinary tract. Urinary tract consists of kidneys, ureters, bladder and urethra. 
Urine flows from kidneys to bladder through ureters and is excreted via urethra.  Modified from 
https://oncologypro.esmo.org/Education-Library/Essentials-for-Clinicians/Genitourinary-
Tract-Tumours/Tumours-of-the-Urinary-System, 14.12.2019. 
Ureters are about 22 – 30 cm long fibromuscular tubes draining urine from renal pelvis to 
bladder. Urinary bladder is a muscular organ that stores urine until controlled urination. It 
expands or shrinks its volume according to the filling state. Muscles of urethral sphincter 
control the urine flow out of the bladder. When bladder squeezes and urethral sphincter is 
relaxed, urine is discharged through urethra. The tube walls of ureters and urethra are exposed 
to repetitive fluid shear stress and pressure; therefore, they need to be tough but elastic (Singh 
et al., 2018). In males, urethra functions also as a passage for semen. The structure of urethra 
differs between males and females by its length and segments. The male urethra is about 20 cm 
long and divided into three different segments called prostatic, membranous and spongy urethra. 
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The most proximal prostatic urethra, and following membranous urethra, that passes the pelvic 
floor, are lined with pseudostratified columnar epithelium. The most distal segment, spongy 
urethra, is lined with squamous epithelium. (Drake et al., 2015; Hickling et al., 2015; Ross & 
Pawlina, 2011) Female urethra is about 4 cm long, lined with transitional epithelium, called 
uroepithelium, proximally and with squamous epithelium at the distal end (Faiena et al., 2016; 
Ross & Pawlina, 2011). Histologically, the urinary tract, similarly to other excretory canals, 
consists of epithelium, lamina propria, muscularis and adventitia/serosa (Figure 2) (Ross & 
Pawlina, 2011). 
The specialized epithelium called uroepithelium, or transitional epithelium, lines the urinary 
tract from minor calyces of kidney to proximal part of urethra. The bottom cell layer of 
urothelium, called basal cell layer, is attached to dense collagenous lamina propria. Connective 
tissue underneath lamina propria is mainly formed from collagen type I and type III and elastin. 
(Hickling et al., 2015; Orabi et al., 2013; Ross & Pawlina, 2011) The muscularis layer beneath 
the connective tissue is formed from two smooth muscle layers: inner longitudal layer and outer 
circular layer. The muscle layers in urinary tract are mixed with connective tissue and regulate 
the urine flow through the tract. (Ross & Pawlina, 2011; Singh et al., 2018)  
 
Figure 2 Layers of ureter. Cross section of ureter with its histological layers. Modified from 
http://www.histology.leeds.ac.uk/urinary/assets/Ureter_60_6-3x.jpg, 12.12.2018. 
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2.2 Uroepithelium and urothelial cells 
Urothelium has a very important role in preventing toxic substances to permeate from urea to 
blood circulation (Hickling et al., 2015; Ross & Pawlina, 2011). The barrier properties of 
urothelium are one of the highest in human body, even higher than human epidermis (Wu et al., 
2009) and it is highly impermeable to macromolecules and pathogens. Urothelium also 
participates in system homeostasis by transporting ions, creatinine, water and urea out of urine, 
changing the composition of urine along its passage (Khandelwal et al., 2009).  
Urothelium is composed of three cell layers: luminal umbrella cells, intermediate layer and 
basal cell layer (Figure 3). The number of layers in urothelium change in different regions and 
depending on the filling state. Urothelium is able to expand and contract while keeping its tight 
barrier properties intact. Especially in case of bladder, the change can be quite large shifting 
from six intermediate cell layers of empty bladder to just three cell layers in full bladder. 
(Hickling et al., 2015; Ross & Pawlina, 2011) In minor calyces, the urothelium has two cell 
layers, four to five in ureter and up to six in urinary bladder (Ross & Pawlina, 2011). The 
urothelium is in close contact with the surrounding smooth muscle layer, as it regulates the 
expansion and contraction of the uroepithelium tissue (Singh et al., 2018).  
 
Figure 3 Histological structure of the uroepithelium presenting the luminal umbrella cell 
monolayer, intermediate cell layer and basal cell layer attached to lamina propria. Modified 
from https://www.auanet.org/images/education/pathology/normalhistology/normal_urothe 
lium-figureA_Big.jpg, 10.12.2018. 
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The superficial or luminal cell layer consists of monolayer of terminally differentiated umbrella 
cells (also called facet cells or superficial cells). These cells are 25-250 µm in size, often 
multinucleated, concaved cells covering the intermediate cell layer (Khandelwal et al., 2009; 
Ross & Pawlina, 2011). Specialized umbrella cells form strong tight junctions, have specific 
apical layer protein and lipid composition. Umbrella cells can also regulate their surface area 
by endo- and exocytosis. (Khandelwal et al., 2009; Singh et al., 2018) This special umbrella 
cell surface structure is composed of asymmetric unit membranes (AUMs), formed from 
uroplakin plaques, that can also be found in intracellular fusiform vesicles (Southgate et al., 
1999; Wu et al., 2009). The shape of the umbrella cells changes according to the state of the 
urine passage. If the bladder is full, the umbrella cells are squamous and flat, whereas with 
empty bladder they are roughly cuboidal and more dome-shaped. (Khandelwal et al., 2009; 
Ross & Pawlina, 2011) Umbrella cell borders are distinct with ridge visible in scanning electron 
microscope (SEM) -imaging. The ridges are result of interlocked apical cell membranes of 
neighbouring cells that strengthen the tight junctions between the cells, increasing the barrier 
function of the urothelium. (Khandelwal et al., 2009; Ross & Pawlina, 2011) The cells in 
intermediate cell layer are connected to neighbouring cells by desmosomes. The intermediate 
cells of urothelium are single-nucleated pyriform shaped cells and a lot smaller than umbrella 
cells, about 10-15 µm in diameter. (Khandelwal et al., 2009; Ross & Pawlina, 2011) 
Intermediate layer can have five layers, but the number varies by the state of urine passage 
through the urinary tract. When the tissue expands, the layers slide past each other increasing 
the area. (Khandelwal et al., 2009; Southgate et al., 1999) The intermediate cells in the 
uppermost layer are partially differentiated with some observed uroplakins and those cells are 
able to rapidly differentiate into umbrella cells if the umbrella cell layer is damaged 
(Khandelwal et al., 2009; Ross & Pawlina, 2011).  The basal layer cells are small, 
approximately 10 µm, single nucleated, and are attached to the lamina propria by 
hemidesmosomes and to intermediate layer by desmosomes (Khandelwal et al., 2009).  
Urothelium has relatively slow turnover, up to 6 months (Khandelwal et al., 2009; Lee, 2011; 
Wu et al., 2009). However, when damaged, the urothelial cells proliferate quickly to regenerate 
the breach (Kreft et al., 2005; Singh et al., 2018), which is critical in order to protect the 
surrounding tissues from acidic urine. When the urothelium is damaged, the damaged cells are 
destroyed and underlying basal cells proliferate rapidly. The stem cell-like cells are among basal 
cells, and allow the rapid regeneration of damaged urothelium (Hickling et al., 2015; Ho et al., 
2012; Ross & Pawlina, 2011) The  cells of intermediate cell layer below the umbrella cells are 
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capable to rapidly differentiate to form new terminally differentiated umbrella cells. (Kreft et 
al., 2005; Lee, 2011) 
2.2.1 Cytokeratins 
Cytokeratins (CKs) are a group of polypeptides which form intermediate filament matrix in 
most of the epithelial cell types. Currently there are twenty identified human cytokeratins that 
are named CK1-CK20 in decreasing molecular weight order. Each epithelial cell type has their 
own characteristic set of cytokeratins and their expression can be used to assess the 
differentiation or maturation stages of specific epithelial cell type. (Southgate et al., 1999) 
Urothelial cells have extensive cytokeratin network. The expressed cytokeratins vary between 
the urothelium cell layers and can therefore be used as an indication of the cell differentiation 
rate. All urothelial cell layers express cytokeratins CK7, CK8, CK18 and CK19. Cytokeratins 
CK5 and CK17 can only be found in basal cells, whereas, CK13 and CK14 are expressed in 
intermediate and basal cells but not in the umbrella cells. (de Graaf et al., 2017; Khandelwal et 
al., 2009; Southgate et al., 1999)  The CK20 is mainly present in differentiated umbrella cells, 
however, some cells in intermediate layer can also express the CK20 (Southgate et al., 1999). 
In immunological characterizations, anti-pan-cytokeratin [AE1/AE3] marker can be used to 
assess the overall cytokeratin expression identifying urothelial cells. AE1 contains CK10, 
CK13-16 and CK19, and AE3 contains CK1-8 (Denstedt & Atala, 2009). Further, neoplastic 
transformation of urothelium, called transitional cell carcinoma, changes the CK expression of 
urothelial cells. Therefore, changes in urothelial cytokeratin patterns can be used as tool for 
cancer diagnostics. (Southgate et al., 1999)  
2.2.2 Asymmetric unit membrane and uroplakins 
The terminally matured and differentiated umbrella cells of urothelium have apical membranes 
composed of differentiated urothelial plaques. These plaques form the AUMs on the apical side 
of the umbrella cells. (Khandelwal et al., 2009; Olsburgh et al., 2003; Singh et al., 2018; Wu et 
al., 2009) Majority of the urothelial apical surface, up to 90 %, is covered with AUMs. AUMs 
can also be found in fusiform vesicles, controlled by cytokeratin network, inside the umbrella 
cells (Khandelwal et al., 2009; Lee, 2011; Southgate et al., 1999; Wu et al., 2009). These AUM 
plagues are formed by glycoproteins called uroplakins (UP) that are highly conserved in 
mammals. They are expressed only in terminally differentiated superficial urothelial cells and 
are therefore used as a major urothelial cell differentiation marker. (Lee, 2011) UCs are 
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characterized with expression of UPs in superficial cell layer, and characteristic CK profiles of 
different layers of urothelium (de Graaf et al., 2017; Khandelwal et al., 2009; Southgate et al., 
1999). Some intermediate cells connected to umbrella cells do express some UPs, as they are 
readily able to differentiate into new umbrella cells if needed (Khandelwal et al., 2009). 
Uroplakins have five different forms (UPIa, UPIb, UPII, UPIIIa and UPIIIb), each having their 
own role in forming plaques. (Kątnik-Prastowska et al., 2014; Khandelwal et al., 2009) Tight 
gap, called the hinge-region, between AUMs is occupied with urohingin and non-plague 
proteins such as ion channels (Khandelwal et al., 2009). One AUM plaque is formed from six 
UP-tetramers, where UPIa/UPII heterodimers form the inner ring and UPIb/UPIII the outer ring 
of the structure (Figure 4) (Kątnik-Prastowska et al., 2014; Khandelwal et al., 2009). 
UPs are critical in forming the barrier properties of the urothelium by forming the AUM plagues 
(Wu et al., 2009). Additionally, UPs trigger immune response leading to apoptosis, when 
umbrella cells become infected (Hickling et al., 2015; Khandelwal et al., 2009). Further, 
abnormal expression of UPs leads to leakage of urothelium and increase the risk of E. coli 
infections. (Hickling et al., 2015; Kątnik-Prastowska et al., 2014; Khandelwal et al., 2009)  
 
Figure 4 Structure of AUM plaques present in apical umbrella cells. Plagues are formed from 
six transmembrane UP tetramers with UPIA/UPII -dimer in the inner ring and UPIB/UPIIIA -
dimer in the outer ring. Modified from Kątnik-Prastowska et al., 2014. 
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2.3 Female pelvic floor 
The bony pelvis consists of two hip bones connected to pubic symphysis at front and to sacrum 
at back. The pelvic cavity can be divided to two areas: upper major pelvis and lower minor 
pelvis. Abdominal organs are positioned in the major pelvis, whereas the organs situated in the 
inferior pelvic area are the lower urinary tract organs (bladder and urethra), genital organs 
(vagina, uterus) and colorectal organs (anus and rectum). (Drake et al., 2015; Herschorn, 2004)  
The inferior pelvic opening is covered with pelvic floor, or pelvic diaphragm, that keeps the 
organs in place. The fibromuscular pelvic floor has openings for urethra, vagina and anus, but 
otherwise it covers the opening. Pelvic diaphragm is composed of important collaboration of 
muscles and connective tissue (Figure 5). (De Lancey, 2016; Drake et al., 2015) The connective 
tissue component of pelvic floor is most importantly composed of endopelvic fascia and 
tendinous arch. The role of the connective tissue in pelvic floor is to suspend the organs in their 
positions. The organs of minor pelvis are all attached to the endopelvic fascia that is bound to 
pelvic walls. (Ashton-Miller & DeLancey, 2007; Herschorn, 2004) The fascia support system 
is divided into three levels. In level one, the cervix and upper proportion of vagina are 
suspended to pelvic walls by ligaments. In level two, the middle segment of vagina is attached 
to tendinous arch. In level three, the most distal segment of vagina is connected to muscles of 
pelvic floor and perineal body. (De Lancey, 2016) The muscular component of the pelvic 
support is primarily formed by levator ani and coccygeus muscles spreading over the pelvic 
opening from both sides, meeting at the middle. These muscles continuously work to keep the 
openings of pelvic floor closed and carry the weight of the organs resting above. Thus, the 
muscles cancel out the stress subjected to the pelvic floor connective tissue, preventing the 
overworked stretching of the pelvic fascia. (Ashton-Miller & DeLancey, 2007; De Lancey, 
2016) 
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Figure 5 Connective tissue and muscles of female pelvic floor. Pelvic floor is supported by 
levels of the connective tissue support and the large layers of pelvic floor muscles forming the 
pelvic diaphragm. Modified from (Kiilholma & Nieminen, 2009) and (Greenwell & Cutner, 
2018). 
Histologically, the pelvic floor support system is composed of smooth muscle cells (SMCs), 
fibroblasts, myofibroblasts and supportive extra cellular matrix (ECM). ECM surrounds the 
cells and is composed of complex cross-linked network of collagens, elastin, proteins, 
proteoglycans, fibronectin, growth factors and glycosaminoglycans. (Alperin & Moalli, 2006; 
Chapple et al., 2015; Singh et al., 2018). The pelvic ECM consists of collagens, mainly types I 
and III, and elastin, and is produced by fibroblasts and myofibroblasts. Fibroblastic cells 
produce and constantly regulate ECM composition. The support of fascia is dependent on the 
ratio of fibroblastic cells’ anabolic and catabolic functions. With dysfunctional balance, the 
composition of fascia is altered, leading to disrupt of the pelvic fascia support system. (Ruiz-
Zapata et al., 2016) 
11 
 
The collagen fibres are the main factors determining the tissue strength. Collagen is a fibrillar 
protein formed from three α-polypeptide chains. The types of α-polypeptides vary between 
different collagen types and are thus used for their characterization. (Alperin & Moalli, 2006) 
Collagen type I forms large fibres with high tensile strength, the force it withstands before 
breaking. It is the predominant collagen type in tissues under a lot of strength such as ligaments, 
tendon and bone. Collagen type III forms smaller fibres and have lower tensile strength and is 
the main collagen type in tissues with high flexibility and periodic stress, such as blood vessels, 
but also in vagina and pelvic floor. (Alperin & Moalli, 2006; Zhou et al., 2012) Collagen types 
I and III form copolymers and their ratio is important for the normal functionality of the 
connective tissue. The altered collagen ratios may have a role in weakened support of the pelvic 
floor (Alperin & Moalli, 2006; Zhou et al., 2012).  
Another important protein in connective tissue is elastin, an insoluble polymer that gives the 
tissue elastic properties. It enables the tissue to be stretched, bent or compressed and revert to 
its original state; important for functions of both vagina and male urethra. Along with collagen, 
it is a central factor in maintaining pelvic floor support. (Alperin & Moalli, 2006; Chapple et 
al., 2015; Ribeiro-Filho & Sievert, 2015) Elastin is stable in adults with low turnover (Klutke 
et al., 2008; Ribeiro-Filho & Sievert, 2015). During pregnancy however, elastin metabolism 
increases to compensate the structural changes occurring in the pelvic area. (Alperin & Moalli, 
2006; Klutke et al., 2008) It has been shown that abnormal elastin metabolism is associated 
with pelvic organ prolapse (POP) and stress urinary incontinence (UI) in women. (Alperin & 
Moalli, 2006; Chapple et al., 2015; Chen et al., 2008)  
2.4 Defects  
2.4.1 Urethral defects 
Urethral defects are common and often result of traumas, infections, iatrogenic causes or 
congenital disorders such as hypospadias (Horiguchi, 2017; Yamzon et al., 2008).  
Urethral strictures are common and caused by diverse causes such as blunt trauma or other 
injury, lichen sclerosus, sexually transmitted diseases or urinary tract infections. Prevalence of 
urethral stricture disease in UK is 40 per 100 000 in men by age 65 years and increases to over 
100 per 100 000 in men older than 65 years (Spilotros et al., 2018). In stricture, the urethra is 
narrowed due to excessive fibrosis, disrupting the flow of urine. Minor defects may be repaired 
surgically with dilation or incision of the narrowed stricture, but larger scale and recurrent 
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defects need surgical repair with urethroplasty, the reconstruction of urethra. Even though the 
reconstructive surgery of small and large strictures are common, they both have high relapse 
rates and often require reoperations (Chapple et al., 2015). If non-urological tissue is required 
for reconstruction, the harvested oral buccal mucosa graft is the most commonly used urethral 
graft material for urethroplasty  (Atala et al., 2017; Chapple et al., 2015; Horiguchi, 2017)  
Other common urethral defect is the congenital disorder hypospadia. Hypospadias are quite 
frequent congenital disorders and their occurrence is about 1 in 300 male infants (Abbas et al., 
2018; Versteegden et al., 2017). In hypospadia, the urinary meatus is misplaced ventral to penis 
with abnormal penis curvature due to the unsuccessful closure of the urethral folds during fetal 
development (Abbas et al., 2018; Keays & Dave, 2017). Large hypospadias are extremely 
challenging to repair with existing methods. The reconstructive surgery is challenging with high 
risk for complications leading to reoperations. Typical complications include fistulas, urethral 
strictures and reopening of the operation site. Further, failed hypospadia surgery is one of the 
common reasons for the urethral stricture disease. (Abbas et al., 2018; Keays & Dave, 2017; 
Spilotros et al., 2018) Variety of tissue grafts such as skin grafts, buccal mucosa or bladder 
mucosa have been used for hypospadia repair (de Kemp et al., 2015). At present, clinicians are 
successfully utilizing oral buccal mucosa to repair complex urethral strictures and hypospadias 
and it is considered as the best urethral substitute in urethroplasty surgery (Atala et al., 2017; 
Horiguchi, 2017). Oral tissue can be harvested quite safely, and its histological structure 
resembles that of urothelium. It is also sturdy enough for surgical utilization. However, the 
donor site availability is very limited and thus another solution is needed for larger defect 
repairs. (Chapple et al., 2015; Horiguchi, 2017; Singh et al., 2018). Further, the currently used 
repair grafts may also fail over time since most of the hypospadia repair surgeries are executed 
during the early childhood and the grafts may not keep up with the pubertal development 
leading to stricture or secondary chordee. (Abbas et al., 2018; Keays & Dave, 2017; Spilotros 
et al., 2018) 
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2.4.2 Pelvic floor defects 
UI and POP are common pelvic floor defects in women, and they often co-exist together 
(Chapple et al., 2015). However, in this text the focus is in the introduction of POP.  
POP, or urogenital prolapse, is a common condition affecting large number of women. In POP, 
the normal support of pelvic floor is weakened, leading to prolapse of lower pelvic organs to 
the vaginal opening. It is defined as descent of the anterior and/or posterior vaginal wall, the 
uterus and/or the vaginal apex. (Jelovsek et al., 2007; Lobo et al., 2017; Osborn et al., 2013) 
Anterior vaginal wall is the most common segment to prolapse leading to descent of bladder. 
Prolapse of vaginal apex leads to prolapse of uterus or after hysterectomy (removal of uterus) 
to descent of small intestine, bladder or colon. Rectum can be descended in case of posterior 
vaginal wall prolapse. The herniation of intestines through vaginal wall is called enterocele. 
(Jelovsek et al., 2007) Types of POP are presented in Figure 6. 
 
Figure 6 Types of pelvic organ prolapse. Depending on the weakened support wall, different 
organs can be prolapsed into the vaginal opening. Anterior vaginal prolapse is the most common 
type of POP. Hysterectomy gives rise to possibility of bowel prolapse. Modified from Barber, 
2016. 
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POP is likely a multifactorial condition. The weakened support of pelvic floor has been 
associated for instance with pregnancy, vaginal delivery, higher age, obesity, genetic factors 
and hysterectomy (Chapple et al., 2015; Lobo et al., 2017; Norton & Brubaker, 2006; Vergeldt 
et al., 2015). Even though one single cause cannot be stated, the injuries caused by vaginal 
delivery, especially instrumental vaginal delivery, appears to be the most common cause 
associated to prevalence of POP. The injuries to pelvic floor levator ani muscles significantly 
weaken the pelvic support capability, also leading to weakening of the connective tissue support 
through over stretching the fascia. (Ashton-Miller & DeLancey, 2007; De Lancey, 2016; 
Herschorn, 2004; Jelovsek et al., 2007) Additionally, POP may be associated with 
dysfunctional fibroblastic metabolism and weakened muscle control (Ruiz-Zapata et al., 2016). 
The altered fibroblastic metabolism leads to disturbances in collagen and elastin synthesis in 
connective tissue. Patients suffering from POP have decreased quantities of collagen and elastin. 
Further, it has been shown, that the collagen and elastin fibres are disorganized, and their 
content is altered, leading to increased stiffness. (Alperin & Moalli, 2006; Chapple et al., 2015; 
Klutke et al., 2008; Ruiz-Zapata et al., 2016) 
The prevalence of POP in routine gynaecological examination of postmenopausal women is 
approximately 43-76 % but only small portion of women, approximately 3-6 % develop 
symptoms. The women often become symptomatic when the prolapsed organ descents beyond 
the hymen. The symptoms include vaginal bulging, pelvic pressure, low back pain, bleeding or 
discharge. (Jelovsek et al., 2007; Lobo et al., 2017; Vergeldt et al., 2015) The lifetime risk for 
women to undergo surgery due to POP is 11-19 %. However, after primary surgery, even up to 
30 % of patients will need at least one reoperation. (Alperin & Moalli, 2006; Hung et al., 2010; 
Medel et al., 2015; Osborn et al., 2013) In the reconstruction, the primary approach is to use 
patients’ own tissue.  However, if it fails and needs reoperation, the recurrent prolapse is usually 
reconstructed with nonabsorbable synthetic polypropylene mesh. Yet, the synthetic meshes are 
prone to complications such as pain, bleeding, sexual dysfunction, mesh erosion, formation of 
fistulas and infection. (Medel et al., 2015; Osborn et al., 2013; Roman et al., 2015) Due to these 
adverse effects, the U.S. Food and Drug Administration (FDA) has announced that use of mesh 
can lead to serious complications and if possible, the use of surgical synthetic mesh should be 
avoided (FDA, 2011). Currently, extensive research is conducted to develop replacing methods. 
Tissue engineering provides possible resolution for the use of synthetic mesh. Using 
biodegradable materials and cells, the support capability of pelvic fascia could be regenerated 
without using permanent synthetic materials. 
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2.5 Cells in urological and gynaecological tissue engineering 
Ideally, the cells used in tissue engineering would be autologous harvested cells expressing the 
desired tissue specific attributes able to regenerate the damaged tissue, for example vaginal 
stromal cells for vaginal stroma, and urothelial cells for urothelium. However, harvest of 
specific desired primary cells can be challenging, and limited, and thus also different cell types 
have been tested to be used as substitutes.  
Urothelial cells (UCs) can be fairly easily isolated and expanded in vitro, further, the UCs are 
studied for urethral reconstruction with promising results (Elsawy & de Mel, 2017; Fraser et 
al., 2004; Southgate et al., 2002), however also other cell types, for instance buccal mucosa 
keratinocytes and fibroblasts (Bhargava et al., 2004; Zhou et al., 2017), epidermal cells (Fu et 
al., 2007) and mesenchymal stem cells of different origins (Li et al., 2013; Li et al., 2014; Tian 
et al., 2018; Wu et al., 2011) have been tested for urological applications. In a rabbit study by 
Fu et al., foreskin epidermal cells were seeded on acellular bladder matrix. The cells were able 
to form layered cell structure and regenerate urethral structure. (Fu et al., 2007) Regeneration 
of smooth muscle layer is highly important in urethral tissue engineering since it could prevent 
the development of strictures in urethral grafts (Maya et al., 2010). Co-culturing SMCs with 
UCs has given promising results for urethral regeneration (De Filippo et al., 2002; Raya-Rivera 
et al., 2011; Zhang et al., 2017). However, in vitro cultured SMCs rapidly lose their phenotype 
and cannot be cultured extended periods of time (Denstedt & Atala, 2009). To overcome the 
muscle cell senescence in vitro, mesenchymal stem cells (MSCs) have been studied in co-
cultures with easily harvestable adipose derived stem cells (ASCs), for example (Wu et al., 
2011; Zhao et al., 2012). 
The vaginal fascia is mainly composed of fibroblastic cells, and their harvest requires surgical 
invasion. More easily harvestable oral buccal mucosa fibroblasts (OF) have been studied for 
use in pelvic floor applications and urethral repair. (Mangera et al., 2013) To overcome the 
need for surgical cell harvest, MSCs have also been studied for fascia tissue engineering 
applications (Lee et al., 2006; Roman et al., 2015).  
2.5.1 Human uroepithelial cells  
hUCs have been used widely in urological tissue engineering, since their isolation and culture 
are well established in literature (Elsawy & de Mel, 2017; Fraser et al., 2004; Southgate et al., 
2002). Primary autologous hUCs can be isolated from tissue biopsies (Southgate et al., 2002) 
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or bladder washing (Fossum et al., 2003). They grow adherently in vitro and have typical 
epithelial cobblestone-like morphology as presented in Figure 7.  
Human UCs are widely used in urethral tissue engineering both in vitro and in vivo (de Kemp 
et al., 2015; Fossum et al., 2007; Raya-Rivera et al., 2011; Zhang et al., 2017). Autologous in 
vitro-expanded hUCs have been successfully used for repairing defected urethra in clinical 
studies (Fossum et al., 2007; Raya-Rivera et al., 2011). Human UCs have also been used to 
regenerate functional bladder (Atala et al., 2006). However, the hUCs implanted in vivo often 
need layer of SMCs in order to effectively regenerate the functional uroepithelium (Atala et al., 
2006; de Kemp et al., 2015; Raya-Rivera et al., 2011). 
Unfortunately, functional urothelium barrier has been difficult to sustain in in vitro conditions. 
The isolated fully matured hUCs gradually lose their differentiated phenotype in vitro and 
expression of UPIII decreases (Xu et al., 2015). The in vitro cultured hUCs lack some key 
properties of urothelium: the mature expression of uroplakins forming AUMs and proper tight 
junctions (Singh et al., 2018). The in vitro cultured hUCs are able to synthesize UPs in their 
endoplasmic reticulum (ER), but the UPs do not form necessary dimers for their functionality 
(Lee, 2011). Additionally, the in vitro expansion of hUCs has been insufficient in many studies 
and the ultimate uroepithelium maturation is not fully achieved in vitro. It is still not sufficiently 
known how the urothelial cells differentiate and what exactly the actual origin of different 
uroepithelium cell types is. (Singh et al., 2018)  
 
Figure 7 Light microscopy image of hUCs. Confluent layer of cultured hUCs in vitro in a 
culturing flask. Scale bar 100 µm.  
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2.5.2 Human adipose derived stem cells 
MSCs have been studied for tissue engineering applications, as they can differentiate towards 
several different cell types. Further, the isolation of MSCs is straightforward, and they do not 
face the ethical problems of embryonal stem cells. MSCs also secrete cytokines and growth 
factors and thus regulate their surrounding cell and tissue growth. (Elsawy & de Mel, 2017; 
Ferraro et al., 2016; Singh et al., 2018; Tian et al., 2018). MSCs can be isolated from various 
sources for example from bone marrow, adipose tissue, dental tissue, amniotic membrane and 
skin.  The bone marrow derived mesenchymal stem cells (BMSCs) are thought as the standard 
MSCs that other MSCs are compared to. (Elsawy & de Mel, 2017; Sterodimas et al., 2010; 
Ullah et al., 2015)  
Many of the MSC harvest sites are limited, excluding the adipose tissue that is readily available. 
The MSCs isolated from adipose tissue are named adipose derived stem cells (ASCs). ASCs 
display stable growth and proliferation kinetics and multipotency to differentiate into variety of 
cell lineages, such as bone, fat, muscle, neural, epithelial and cartilage cells (Li et al., 2014; 
Rodriguez et al., 2006; Shi et al., 2012; Sterodimas et al., 2010; Ullah et al., 2015). The 
differentiation can be directed by using conditioned culture medium or culturing in co-cultures 
(de Graaf et al., 2017; Li et al., 2013). ASCs are easily harvested from excess adipose tissue 
resulting from liposuctions or surgical procedures. They perform well in long-time culture, 
remaining stable with low level of senescence (Rodriguez et al., 2006). They grow adherently 
when cultured in vitro and have spindle-like morphology (Figure 8). Due to their abundance 
and easy isolation, hASCs could be potential stem cell type for urological tissue engineering 
(Elsawy & de Mel, 2017) ASCs are isolated from heterogeneous stromal vascular fraction 
(SVF) cells of the adipose tissue. The SVF is composed of stromal cells, ASCs and 
microvascular cells  (Ferraro et al., 2016; Lindroos et al., 2011). The stem cells are identified 
amongst the SVF cells by their specific cell surface markers called clusters of differentiation 
(CD) (Ferraro et al., 2016; Ullah et al., 2015). The ASCs have been shown to express 90 % 
identical CD profile with BMSCs as are thus thought to be good alternative for BMSCs (Ferraro 
et al., 2016). 
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Figure 8 Confluent hASCs. Layer of cultured hASCs in vitro. Scale bar 100 µm. 
ASCs can differentiate into SMCs, which are important in urothelium regeneration (Garriboli 
et al., 2014; Li et al., 2014; Shi et al., 2012) and the SMCs contribute to the contractility of 
uroepithelium. MSCs co-cultured with urothelial cells aim to induce the formation of urethral 
stroma and angiogenesis, which has been a major challenge in urethral tissue engineering 
(Pangesty et al., 2017). There are studies, which indicate that the hASCs can differentiate 
towards urothelial cell type, however, these cells do not sufficiently express the key markers 
crucial for urothelium barrier properties, such as the UPs and tight junctions (Shi et al., 2012; 
Singh et al., 2018). In urethral tissue engineering, hASCs have been used both to differentiate 
into SMCs (Rodríguez et al., 2009; Zhao et al., 2012) and UCs (Liu et al., 2009; Shi et al., 2012; 
Zhang et al., 2013).  Human ASCs were selected for this study for studying smooth muscle 
regeneration for urethral tissue engineering, since they are readily available and able to 
differentiate towards SMCs (Ferraro et al., 2016; Garriboli et al., 2014; Maya et al., 2010).  
2.5.3 Human vaginal stromal cells 
Human vaginal stromal cells (hVSCs) are the cells of vaginal connective tissue, consisting of 
fibroblasts and myofibroblasts (Alperin & Moalli, 2006; Chapple et al., 2015). These 
fibroblastic cells produce the ECM and regulate its composition continuously (Alperin & 
Moalli, 2006; Ruiz-Zapata et al., 2016). They are adherent cells and appear elongated when 
cultured in vitro (Figure 9). 
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Figure 9 Layer of hVSCs. Human VSCs cultured in culture flask. Scale bar 100 µm. 
Fibroblasts are activated to differentiate into myofibroblasts. Extracellular signal molecule 
transforming growth factor beta 1 (TGF-β1) recruits fibroblasts and regulates their 
transdifferentiation to myofibroblasts (Hinz et al., 2001; Ruiz-Zapata et al., 2016; Sun et al., 
2016). Myofibroblasts are contractile fibroblasts that combine features of SMCs and fibroblasts. 
They are characterized by expression of alpha-smooth muscle actin (αSMA). (Denstedt & Atala, 
2009; Jones & Ehrlich, 2011) Alpha-SMA gives myofibroblasts their contractile capability, and 
it is similar to actins in SMCs (Hinz et al., 2001). Myofibroblasts are the main fibroblastic cell 
type in pelvic floor fascia and connective tissue (Chapple et al., 2015; Ruiz-Zapata et al., 2016). 
Human VSCs have been successfully expanded in vitro and implanted in vivo to regenerate 
natural-like fascia (Hung et al., 2010).   
2.6 Biomaterials in urological and gynaecological tissue engineering 
Tissue engineering can be used for developing more suitable grafts for urethral and pelvic 
defects, but the best biomaterial for these applications has not yet been established. Biomaterials 
can be classified to natural and synthetic biomaterials. The natural biomaterials include natural 
polymers, such as collagen, and acellular tissue matrixes, whereas the synthetic biomaterials 
contain synthetic polymers. (Kim et al., 2000) The biomaterials in tissue engineering function 
as an artificial ECM and needs to be carefully selected for desired application to resemble the 
mechanical properties of the natural tissue. Many different approaches with natural and 
synthetic materials have been studied, yet still the materials lack the sufficient mechanical 
design and functionality to regenerate the biological functions. (Chapple et al., 2015; Nair & 
Laurencin, 2007; Singh et al., 2018)  
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Generally, the materials in tissue engineering have few essential requirements. The scaffold 
materials need to be immunologically inert, biocompatible and bioactive. Scaffold should be 
biodegradable and enhance the cell ingrowth to sustain the reconstruction of natural tissue. If 
the biocompatibility and bioactivity are not suitable for the target tissue, the site may face 
serious fibrosis and other complications. The scaffold guides the regeneration of the tissue and 
thus enhances the integration of the surrounding tissue. In this, the material physical properties, 
porosity, fabrication, degradation rate and degradation product fate are important. (Abbas et al., 
2018; Chapple et al., 2015; Kim et al., 2000; Nair & Laurencin, 2007; Singh et al., 2018) Also, 
the material should have adequate self-life to be used in clinical applications (Nair & Laurencin, 
2007).  
Scaffolds can be used with or without seeded cells, but without pre-seeded cells the scaffold 
needs to promote cell migration on site into the degrading scaffold. However, the in situ 
regenerating capacity might not be enough, and there is a risk of graft shrinkage, fibrosis and 
poor tissue replacement (Chapple et al., 2015; Singh et al., 2018).  
2.6.1 Natural biomaterials 
Many kinds of autologous, allogeneic and xenogeneic natural materials have been studied for 
their suitability in urological and gynaecological tissue engineering. Natural biomaterial 
availability is limited, as they are harvested from animals or humans, and batch-to-batch 
variations are high.  Natural biomaterials used for tissue engineering include acellular matrices, 
collagen and silk, for example. Existing problems with natural biomaterials are the shrinkage 
of the scaffold and risk for acute inflammatory response at implantation site leading to fibrosis.  
(Chapple et al., 2015; Horiguchi, 2017; Kim & Mooney, 1998)  
Acellular matrices, such as human dermis, porcine small intestine submucosa (SIS) and porcine 
bladder acellular matrix graft (BAMG), are common natural biomaterials used in tissue 
engineering (Davis et al., 2018; de Kemp et al., 2015; Herschorn, 2004; Singh et al., 2018). Use 
of acellular matrices is based on the utilization of the natural collagen-rich ECM construct after 
the removal of all cellular components. In acellular matrices, the ECM stays very similar to 
ECM in natural tissue and has specific collagen matrix with bioactive molecules and growth 
factors. These bioactive molecules enhance specific cell interactions and maturation and are 
efficient in supporting cell growth and migration. However, the ECM composition does alter 
between tissues, so the desired properties need to be considered when selecting source of used 
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ECM. (Kim et al., 2000; Kim & Mooney, 1998; Ribeiro-Filho & Sievert, 2015; Singh et al., 
2018)  
Prepared acellular matrices can be applied unseeded or seeded with selected cell types. In 
unseeded approach, the ECM construct is implanted in vivo, and cells from surrounding tissue 
are then migrating into the scaffold. However, in urethral repair, the unseeded scaffolds are 
appropriate only for smaller defects as their regenerating ability is sufficient only in short 
distances of about 1 cm (Davis et al., 2018; Dorin et al., 2008). Seeded scaffolds can be used 
for larger defect repairs, in vivo studies indicate, that they benefit from the paracrine function 
of the pre-formed cell layer further promoting tissue regeneration. (Davis et al., 2018) Using 
cell-seeded scaffolds in urethral applications has been shown to be more favourable since it 
may decrease the risk of the development of fibrosis and strictures (De Filippo et al., 2015; 
Singh et al., 2018).  
Even though acellular matrices have been successfully utilized and have advantages in cell 
signalling and attachment, numerous complications arise from using natural acellular 
biomaterials. The natural materials degrade rapidly and pose a thread of immune-rejection and 
disease transmission. The most common complications emerging are graft shrinkage, urethral 
strictures, especially in longer defects, infections, stenosis and major scarring. All these lead to 
dysfunction of the organ, which causes great distress for the patient.  (de Kemp et al., 2015; 
Elsawy & de Mel, 2017; Garriboli et al., 2014; Maya et al., 2010; Zhang et al., 2014) 
Collagen is in the key role when using acellular matrices, as it is the major component of the 
natural ECM. It can be easily isolated, causes minimal inflammatory response and enhances the 
cell attachment. (Kim et al., 2000) Collagen’s mechanical properties can be altered with 
crosslinking and it can be processed into several structures to be used as scaffolds (Fu et al., 
2007; Pinnagoda et al., 2016; Yao et al., 2017). Pinnagoda et al. manufactured an acellular 
tubular collagen scaffold for urethral regeneration and achieved natural-like urethral tissue even 
in 2 cm defect (Pinnagoda et al., 2016). Possibility of using acellular grafts also for larger 
repairs would bypass the cell harvesting and culturing step and thus decrease the time and 
money consumption. Increasing knowledge on biomaterials and their fabrication may expand 
the capacities of unseeded matrices for larger scale repairs also.  
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2.6.2 Synthetic biomaterials 
In general, natural biomaterials are insufficient for larger scale repairs, and thus artificial 
biomaterials are needed. The synthetic nonabsorbable polypropylene mesh used for repair of 
hernias and POP also needs a safer substitute (Chapple et al., 2015). Synthetic biodegradable 
polymer scaffolds are the most promising materials for scaffold design, as the scaffold is 
purposed to degrade as the tissue regenerates. Their molecular composition is well-known, and 
their function is predictable and modifiable. Material properties can be designed and altered by 
combining different synthetic polymers. (Denstedt & Atala, 2009; Dorati et al., 2014) Synthetic 
polymeric materials vary by their chemistry, solubility, hydrophilicity and hydrophobicity, 
surface energy, water absorption and degradation mechanisms, for example (Nair & Laurencin, 
2007). By careful design, the material can be adapted for the functional and structural 
requirements of desired cells and tissues in planned applications (Denstedt & Atala, 2009; 
Dorati et al., 2014). The research for the best synthetic biomaterial for urological and 
gynaecological tissue engineering is still ongoing. The typical problems with synthetic 
materials are that they are lacking the natural cell recognition sites, are less bioactive and more 
hydrophobic compared to natural biomaterials which leads to weaker cell attachment (Kim & 
Mooney, 1998; Maya et al., 2010). The synthetic biomaterials have different mechanical 
properties compared to natural tissue, the synthetic materials tend to have too high mechanical 
strength and stiffness. However, their mechanical properties can be changed and controlled, 
and the large-scale manufacturing is relatively easy with lower batch-to-batch variations 
compared to natural biomaterials. (Elsawy & de Mel, 2017; Kim & Mooney, 1998) 
The most investigated polymers for urological and gynaecological applications are 
biodegradable polymers of poly-L-lactide (PLLA), polycaprolactone (PCL), and poly(lactic-
co-glycolic acid) (PLGA) (Abbas et al., 2018; Dorati et al., 2014; Hung et al., 2010; Mangera 
et al., 2013; Roman et al., 2015). They belong into a group of thermoplastic poly(α-ester)s, 
which are the most extensively studied class of biodegradable polymers. Additionally, they are 
generally used polymers for other biomedical applications, such as absorbable sutures. (Nair & 
Laurencin, 2007)  
The properties of poly(α-ester)s are easily tailored for desired applications by forming 
copolymers and altering their monomer ratios (Abbas et al., 2018; Nair & Laurencin, 2007).  
Poly(α-ester)s are aliphatic polymers whose ester bonds degrade by hydrolysis. Their 
degradation products are natural metabolites that are secreted from the body as water and carbon 
dioxide. They can be fabricated with various techniques to achieve variety of shapes and forms. 
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(Kim & Mooney, 1998; Nair & Laurencin, 2007) However, their molecular structure lacks 
functional groups, which cuts back ability for covalent modifications (Kim & Mooney, 1998).  
PLLA belongs into group of poly(α-hydroxy acid)s (Kim & Mooney, 1998). It is a semi 
crystalline polymer, with crystallinity of 37 % and tensile modulus of 4.8 GPa. It is hydrophobic 
and thus its degradation time is not very rapid; two to 5.6 years for total absorption in vivo. The 
degradation rate is dependent on the porosity of the matrix controlling the water diffusion into 
the scaffold. The slow degradation time of PLLA is being compensated by combining it to co-
polymers with more rapidly degrading polymers. (Nair & Laurencin, 2007)  
PCL is a polyester formed from monomers of ε-caprolactone. It is a versatile material, as it is 
soluble into a variety of organic solvents and easily blended with numerous other polymers. 
PCL has low melting point of 55-60 ̊C and glass transition at -60 ̊C. PCL degrades through 
hydrolysis, but rather slowly, taking two to three years. Therefore, PCL is often copolymerized 
for more rapid degradation time. (Nair & Laurencin, 2007; Shakhssalim et al., 2017) PCL has 
low tensile modulus, about 23 MPa, but can be stretched to over 700 % before breakage. PCL 
has been studied for use in drug delivery devices due to its relatively slow rate and high 
permeability for various drugs. Further, PCL is also an interesting material for tissue 
engineering applications. PCL is flexible and has good load-bearing capacity, and has therefore 
been studied in tissue engineering applications for bone, cartilage and muscle regeneration. 
(Garkhal et al., 2007; Nair & Laurencin, 2007)  
2.6.3 Poly(L-lactide-co-ε-caprolactone) 
Poly(L-lactide-co-ε-caprolactone) (PLCL) is a copolymer of PLLA and PCL. The 
copolymerization decreases the degradation time compared to plain PCL, and it can be altered 
for specific applications by changing monomer ratios. Due to the properties of PCL, PLCL is 
also very elastic material. (Laurent et al., 2018; Nair & Laurencin, 2007)  Because being flexible, 
elastic and having controllable degradation properties, PLCL is especially interesting 
biomaterial for soft tissue applications in tissue engineering (Wu et al., 2016). However, PLCL 
is hydrophobic, like many of the synthetic polymers, which limits the attachment of cells in 
tissue engineering applications (Fu et al., 2014). Altering PLA and PCL ratios also adjusts the 
stiffness and elasticity of PLCL. PLA as itself is brittle in nature whereas PCL is elastic. In 
PLCL, PLA forms the stiff domains in soft PCL matrix. (Jeong et al., 2004; Laurent et al., 2018) 
PLCL can be processed into many different scaffold shapes like foams, tubular, electro spun 
fibres and sheets. PLCL has been successfully studied in many tissue engineering applications, 
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including cartilage (Kim et al., 2013), neural (Prabhakaran et al., 2009), ocular (Yao et al., 
2017), gynaecological (Sartoneva et al., 2018; Wu et al., 2016), urological (Sartoneva et al., 
2012) and vascular (Pangesty et al., 2017; Shafiq et al., 2015) applications. PLCL is also 
observed to have shape-memory, which could have benefits in some applications. PLCL can 
also be embedded with growth factors, heparin or other factors to improve cellular responses 
(Laurent et al., 2018). Because of this feature, the PLCL scaffolds in this study were embedded 
with specific ascorbic acid derivate. 
2.6.4 Ascorbic acid 
Ascorbic acid (AA), or vitamin C, is a small carbohydrate functioning as an important reducing 
agent and essential enzymatic cofactor in numerous intracellular pathways (Arrigoni & De 
Tullio, 2002; D’Aniello et al., 2017). Humans obtain their daily intake from nutrients, as 
humans are unable to synthetize AA due to the mutation in L-gulono-lactone oxidase (GLO) 
enzyme needed for AA biosynthesis (Arrigoni & De Tullio, 2002; D’Aniello et al., 2017). 
However, AA is unstable and easily breaks down by oxidation, and forms dehydroascorbate 
(DHA), which can also be reduced back to AA (D’Aniello et al., 2017; Du et al., 2012; Saitoh 
et al., 2013). More stable ascorbic acid derivates (AADs) have been used for cell culture with 
comparable results to AA (Boyera et al., 1998; Du et al., 2012; Mangir et al., 2016; Saitoh et 
al., 2013). AA functions as an antioxidant by reducing reactive oxygen species (ROS) and free 
radicals, and inhibits them from causing tissue damage (Arrigoni & De Tullio, 2002; Saitoh et 
al., 2013). The reducing capability of AA is due to its easy oxidation (Du et al., 2012). AA also 
has a role in epigenetics, as increased AA intake leads to increased histone acetylation 
(D’Aniello et al., 2017; Du et al., 2012). Presence of AA in vitro leads to increased cell 
proliferation rate compared to absence of AA, which causes the cell proliferation to be impaired 
(Fernandes et al., 2009). This can be seen as impaired wound healing in absence of AA as no 
matured collagen can be formed (Kishimoto et al., 2012). The AA thus shows mitogenic effect 
on cells and is essential in cell culture mediums. 
In addition to numerous metabolism processes, AA has an essential role in collagen synthesis. 
It is necessary cofactor for enzymes prolyl hydroxylase and lysyl hydroxylase in post-
translational procollagen modifications in ER prior to extracellular excretion. Without AA, no 
collagen is being modified and secreted, as it needs to be in its native form. (Fernandes et al., 
2009; Piersma et al., 2017; Pozzer et al., 2017) The wrongly modified collagens are degraded 
inside the cells before excretion (Pinnell, 1985). AA is also regulating collagen synthesis by 
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activating collagen gene expression (Mangir et al., 2016). AA has also been shown to affect 
messenger RNA (mRNA) stability; stabilizing collagen mRNA and destabilizing elastin mRNA 
(Arrigoni & De Tullio, 2002).  
AA is associated with mesenchymal stem cell osteogenesis and chondrogenesis (D’Aniello et 
al., 2017; Fernandes et al., 2009). Osteogenesis and chondrogenesis are increased with presence 
of AA through increased collagen synthesis, whereas in absence of AA other differentiation 
lineages are upregulated (Fernandes et al., 2009). However, many studies have shown that AA 
also enhances adipogenesis of MSCs (Cuaranta-Monroy et al., 2014; Weiser et al., 2009), and 
also enhances the generation of induced pluripotent stem cells (Esteban et al., 2010).  
2.6.5 Supercritical carbon dioxide processing 
After scaffold material selection, the scaffold design and fabrication are very important. The 
fabrication method and scaffold design could have an effect on cell attachment and tissue 
regeneration, so developing an optimal fabrication method and design is highly important (Kim 
& Mooney, 1998; Nair & Laurencin, 2007). In tissue engineering, the porous scaffolds structure 
is favourable in most applications. The pore size and overall interconnected material porosity 
have an important role in cell migration and viability. The pores work as pathways for nutrient, 
signalling molecules and oxygen diffusion through the scaffold, enhancing cell viability across 
the material. (Elsawy & de Mel, 2017)  
The 3D porous scaffolds used in this study were fabricated with supercritical carbon dioxide 
(scCO2) foaming to avoid any harmful substances used in other common fabrication methods. 
Supercritical fluid processing for pore formation is an appealing alternative for solvent casting, 
a common fabrication method for forming porous 3D scaffolds. Solvent casting requires toxic 
organic solvents, such as chloroform, leaving cytotoxic residues on the scaffold. Solvent casting 
is also very time consuming. (Kim et al., 2013; Salerno et al., 2015) ScCO2 is the most appealing 
supercritical fluid for medical applications. ScCO2 is non-toxic, inexpensive and non-
flammable supercritical fluid and it is readily available (Kim et al., 2013; Salerno et al., 2015). 
In superficial fluid processing, the supercritical fluid is solubilized inside the polymer matrix, 
and pore formation is controlled with temperature and pressure changes, and thus no toxic 
substances are present. In constant pressure and higher temperatures, the formed pores will be 
larger and more interconnected, as the scCO2 is better able to penetrate between the polymer 
chains in the matrix. In turn, with constant temperatures, the foaming results in many smaller 
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pores. (Kim et al., 2013) This method can also be used to fabricate polymer matrix with 
bioactive compounds (Salerno et al., 2015).  
2.7 Tissue engineering in urethral repair 
Variety of urethral tissue engineering research is ongoing both in vitro and in vivo. The studies 
focus on finding the optimal cell source and material combination to be used in urethral repair, 
as the functional tissue engineered graft has many requirements to be successful. Most 
importantly, the biomaterial needs to contribute to the barrier function of urothelium, provide 
nutrients to cells and enhance smooth muscle generation important for functional urethra. The 
material must be elastic and stabile under pressure, since it will be susceptible for strong fluid 
forces and stress from erectile functions. (Abbas et al., 2018; Elsawy & de Mel, 2017; Singh et 
al., 2018) The current challenges in the present urethral tissue engineering research include 
establishing sufficient barrier properties, maintaining differentiation of the UCs, regeneration 
of urethral smooth muscle layers and vascularization and maintaining contractility with 
available materials (Elsawy & de Mel, 2017; Singh et al., 2018).  
2.7.1 In vitro tissue engineering 
In vitro studies enable the close monitoring of cellular functions and cell-biomaterial 
interactions under controlled study environment. Specific cellular functions are studied in easily 
established cell cultures, before moving on to complex in vivo studies in physiological 
environment in animal or human studies.  
Previously, Wünch et al. compared the adhesion on morphology of the formed urothelium on 
six different commercially available biomaterials. Two of these materials were PLA-based 
synthetic materials, and rest four were derived from porcine or bovine donors and based on 
collagen frameworks. Natural biomaterials did mostly achieve adequate results compared to 
synthetic materials, so they seem to be suitable for urothelial cell culture. However, as the tested 
natural biomaterials are xenogeneic, their usage needs careful consideration. (Wünsch et al., 
2005) The viability and proliferation of hUCs on natural acellular matrices of porcine SIS and 
BAMG were compared by Davis et al. Human UCs remained viable on both matrices, but on 
BAMG the proliferation rate was fourfold higher. They expanded their study by culturing hUCs 
on BAMG in urine. However, the cell proliferation and viability were significantly higher in 
the control group cultured in growth media. (Davis et al., 2011) Generally, SIS isolated in 
laboratory has had better results compared to commercial SIS products. This might be because 
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of the needed safety protocols in manufacturing the commercial products, such as freeze-drying 
and sterilization that alter the commercial SIS properties. (Ribeiro-Filho & Sievert, 2015) 
However, overall SIS seems not to be ideal for UC culture (Davis et al., 2011; Maya et al., 
2010). As the gastro intestinal tract and urinary tract are different in structure, using SIS has a 
high risk for serious complications. The epithelium of SIS has inherent absorptive and secretory 
properties as the urothelium has barrier properties, thus using SIS in urethral repair can lead to 
urine leakage and serious infections. (Singh et al., 2018) 
Xu et al. produced electrospun scaffolds from ureter ECM/PLLA blend and porcine SIS/PLLA 
blend, to benefit from both natural ECM composition and mouldable synthetic biopolymers. 
Scaffolds were seeded with hUCs. Ureter ECM/PLLA scaffold successfully promoted hUC 
viability and proliferation, but also maintained differentiated hUC phenotype. The expression 
of UPIII was significantly higher on ECM/PLLA than in control materials SIS/PLLA and plain 
PLLA. (Xu et al., 2015) Further, Sartoneva et al. compared human amniotic membrane (hAM) 
and PLCL membranes for hUC culture. Human UCs were successfully cultured on plain PLCL 
membranes, which they preferred over hAM. The hUC proliferation was higher, and the 
viability was significantly better on PLCL than on hAM. The hUCs maintained their phenotype 
and proliferated significantly more efficiently than on control materials. (Sartoneva et al., 2011)  
As seen from these example studies, the hUCs have maintained their phenotype, remained 
viable and proliferative in vitro on tissue engineered scaffolds. In vitro studies continue to give 
detailed valuable information on cellular functions when testing new materials and cells for 
urethral tissue engineering. The urethral reconstructive research, however, is already in point 
where in vivo and even clinical studies are done in increasing numbers. 
2.7.2 In vivo tissue engineering and clinical pilot studies 
Urological tissue engineering has already been extended to in vivo studies both with animals 
and clinical studies with humans; many patients have been treated with acellular constructs or 
cell-seeded grafts (Davis et al., 2018). In vivo studies enable the monitoring of the tissue 
engineered construct under physiological conditions that cannot be simulated in vitro. Different 
approaches have been implemented in vivo with promising results. 
In previous in vivo studies, urethral regeneration in dogs was performed by Orabi et al. in their 
study where they seeded tubular BAMG with SMCs and UCs isolated from bladder biopsies. 
The control group with acellular BAMG all formed severe strictures and urine leakage, whereas 
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animals with cell seeded scaffold regenerated functional urethra. (Orabi et al., 2013) Other 
scaffold approach in in vivo study by Tian et al. utilized silk fibroin scaffold. They seeded silk 
fibroin with hASCs and implanted the construct to rabbit urethra. Six weeks post-surgery, 
normal-like urothelium was formed, with underlying SMCs and blood vessels. (Tian et al., 
2018) Further, Zhang et al. bioprinted tubular 3D urethra from polymer blend of PCL/PLCL as 
a matrix. Fibrin hydrogel seeded with UCs and SMCs was simultaneously bioprinted around it. 
SMCs were printed to the outer side of the PCL/PLCL matrix and UCs to the inner side, to 
achieve the natural like layering of the urethra. Graft was then implanted in rabbits. Cells 
remained viable and expressed normal phenotype at least to day seven post-implantation. The 
results were really promising for future of urethral tissue engineering. (Zhang et al., 2017) 
In addition to animal studies, few clinical pilot studies on urethral regeneration have been 
published. Fossum et al. performed a clinical study repairing hypospadia with a graft of 
acellular dermis seeded with autologous hUCs isolated with bladder wash procedure. Six 
patients were treated, out of which four developed complications, and only three expressed 
hUCs on the transplant during the follow-up period. After complications were treated, repaired 
urethras remained functional and patients were satisfied. (Fossum et al., 2007) Further, 
autologous buccal mucosa keratinocytes and fibroblasts were seeded on de-epidermized dermis 
in a pilot study by Bhargava et al. and used for treating urethral strictures in five human patients 
suffering from lichen sclerosus. Two patients needed reoperation of the procedure due to 
formation of fibrosis while the other three needed assisting operations. However, in the end of 
their follow-up periods, no recurrence was reported in any of the patients. (Bhargava et al., 
2008) In addition, Raya-Rivera et al. experimentally treated urethral defects in five boys aged 
10 – 15 years with tubular poly(glycolic acid) (PGA) matrix scaffold, seeded with hUCs and 
SMCs. At the 36-month follow-up, all regenerated urethras were functional, and the tissue 
engineered PGA graft had formed and retained normal urethral architecture. (Raya-Rivera et 
al., 2011)   
Animal studies are essential for studying novel biomaterial and cell combinations to understand 
the host responses and degradation profile after implantation, prior to conducting studies with 
human patients. New novel structures are emerging in attempt to find the clinically optimal 
tissue engineered construct for urethral regeneration. These example studies show that tissue 
engineered constructs have already been used in clinical applications with potential results, 
however, the number of treated patients is small and more evidence on the tissue engineering 
based reconstruction is required.  
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2.8 Tissue engineering in pelvic floor applications 
As the current use of polypropylene mesh for POP correction is prone for complications, 
numerous in vitro studies are ongoing to find the safer compensatory repair material. The 
biomaterials for pelvic floor applications should regenerate and strengthen the natural collagen 
framework of the pelvic support (Chapple et al., 2015). Tissue engineered cell seeded scaffold 
could regenerate the natural supporting fascia by recruiting ECM producing cells to produce 
supportive connective tissue on site. (Aboushwareb et al., 2011; Medel et al., 2015; Roman et 
al., 2015)  
In previous in vitro study, Roman et al. aimed to mimic natural ECM alignment in human fascia 
for treating POP with hASCs cultured on electrospun PLA scaffolds with different degrees of 
fibre alignment. Cells produced more collagen on aligned scaffolds compared to controls, 
growing oriented along the fibre alignment. Their test suggested that the alignment of fibres 
and cells are important for fascial tensile strength and thus supporting the pelvic floor. (Roman 
et al., 2015) Further, Mangera et al. studied seven different scaffold materials in vitro for SUI 
and POP with OFs. These seven materials included AlloDerm® (acellular cadaveric dermis), 
cadaveric dermis, porcine dermis, polypropylene mesh, porcine SIS, sheep stomach and 
electrospun PLA. Out of the seven candidates, SIS and PLA achieved the best cell attachment, 
ECM production and mechanical properties fit for pelvic floor application. (Mangera et al., 
2013) Wu et al. manufactured electrospun PLCL/fibrinogen mesh and studied its potential in 
POP repair. They implanted PLCL/fibrinogen mesh into abdominal wall of dogs but also 
conducted small clinical trial on POP patients. In both studies, the PLCL/fibrinogen mesh 
performed better than nonabsorbable polypropylene mesh with faster vascularization and tissue 
regeneration. PLCL mesh therefore appears to be a promising repair option for POP. (Wu et al., 
2016) 
In addition, tissue engineered fascia graft consisting of hVSCs and biodegradable PLGA mesh 
was tested in vivo in mice by Hung et al. In their study, hVSCs were mixed within collagen 
solution and then seeded onto PLGA mesh. The seeded hVSCs were labelled with fluorescent 
marker on their cell membranes before implantation. Fabricated PLGA mesh was then inserted 
subcutaneously in mice. In their study, they achieved formation of new fascia of human origin 
in the test mice, seen as abundance of the pre-labelled hVSCs in the newly-formed fascial tissue. 
(Hung et al., 2010) Roman et al. studied in vitro for the possibility to use hASCs or OFs as 
alternatives for vaginal cells. The cells were seeded on electrospun PLA meshes, which were 
strained or unstrained in cell culture holders. After 14 days in culture, they determined the cell 
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collagen production and expression of ECM collagen type I and III and elastin. Both cell types 
performed well and produced good amounts of collagen. On unstrained mesh, hASCs produced 
increased amount and denser collagen than OFs. However, on strained mesh, no superiority 
over other was seen in their analyses. Further, elastin production of both cell types was 
increased compared to unstrained conditions. They conclude that both hASCs and OFs can be 
used for pelvic floor tissue engineering. (Roman et al., 2014) 
As pelvic floor support system is very complex structure, its regeneration is not that straight 
forward. Current studies aim for regenerating the connective tissue in pelvic floor, and thus 
studies focus on increasing and improving cell collagen production. Promising results for fascia 
development have been acquired with different approaches, and effects of material properties 
to cellular functions have been unravelled.  
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3 AIMS OF THE STUDY 
This project studies the effect of PLCL scaffolds embedded with AAD on hVSCs, hUCs and 
hASCs. The effect on cell viability, cell proliferation, cell maturation and gene expression are 
determined to evaluate the suitability of the novel PLCL based scaffolds for use in urological 
and gynaecological tissue engineering applications. The study is divided into two phases: 
I. Determining the effect of AAD embedded in PLCL membrane on hVSC viability, 
collagen production and cell maturation and expression of specific genes. 
 
II. Determining the effect of supercritical carbon dioxide foamed PLCL scaffold embedded 
with AAD (scPLCLas) on hUC and hASC viability, collagen production, cell 
maturation and expression of specific genes compared to plain scPLCL. Further, the 
effect of co-culture of hUCs and hASCs is studied on scPLCLas and scPLCL by 
determining the cell viability and phenotype maintenance. Prior to hUC/hASC co-
culture study, different medium compositions are studied in order to optimize the co-
culture medium. 
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4 MATERIALS AND METHODS 
This study was carried out in two consecutive phases: Phase I hVSC seeded PLCL membranes 
and Phase II hUC and hASC monoculture on 3D scPLCL –scaffolds, co-culture medium 
optimization and hUC/hASC co-culture. Below are described the methods used in this study. 
4.1 Biomaterials 
The scaffolds used in this thesis project were manufactured at former Tampere University of 
Technology, Department of Biomedical Sciences and Engineering. In Phase I, three different 
types of PLCL membranes were used: holed PLCL with added ascorbic acid derivate 
(hPLCLas) and unholed PLCL membrane with added ascorbic acid derivate (PLCLas) and 
plain holed PLCL membrane (hPLCL) (Figure 10). Membranes were manufactured from 70/30 
PLCL copolymer granules with inherent viscosity of 1.6 dl/g (Corbion, Gorinchem, The 
Netherlands). Granules, with or without added known amount of AAD, were compression 
moulded with Nike Hydraulics press (Type ZB110 NIKE Hydraulics Ab, Eskilstuna, Sweden) 
into 0.3 mm thick membrane sheet. Twelve mm diameter samples were cut out with laser 
cutting, using Epilog Laser Fusion 75W (Golden, CO, USA) laser cutter, along with the holes 
for holed membranes. Samples were then washed with ethanol, vacuum dried and sterilized by 
minimum of 25 kGy gamma irradiation before cell culture. For the experiment, membranes 
were put in place in wells with CELLCROWN™ (Scaffdex Oy, Tampere, Finland). 
 
Figure 10 PLCL membranes used in Phase I. Three different membranes were studied with 
hVSCs: A) hPLCLas B) PLCLas C) hPLCL. 
In Phase II, two kinds of 3D scaffolds were studied: scPLCLas and plain scPLCL 3D-scaffolds 
(Figure 11). The protocol for scPLCL scaffold manufacturing and characterization was similar 
to as described earlier (Sartoneva et al., 2018). Briefly, 70/30 PLCL copolymer granules with 
inherent viscosity of 1.6 dl/g (Corbion) were used to manufacture the scaffolds. The porous 
interconnected scPLCL scaffolds were produced by transforming PLCL granules into rods by 
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melt-extrusion and then fabricated by custom-fitted scCO2 reactor system (Waters Operating 
Corporation, Milford, MA, USA). Samples were then cut into scaffolds with diameter of 5 mm 
and thickness of 2 - 2.5 mm. The scPLCLas scaffolds were prepared similarly but were 
embedded with known amount of AAD. Scaffolds were washed with ethanol and sterilized by 
gamma irradiation, min 25 kGy, before cell culture. 
 
Figure 11 3D scaffolds used in Phase II. Two different 3D PLCL scaffolds were studied with 
hUCs and hASCs: A) scPLCLas, B) plain scPLCL. 
All scaffolds were prewetted in growth medium in +37 °C for 24 hours prior to plating the 
cells for the experiment. 
4.2 Isolation of cells and cell culture 
4.2.1 Human vaginal stromal cells 
Human VSCs were isolated as described by (Sartoneva et al., 2018)  from vaginal tissue pieces 
from patients undergoing vaginectomy. Briefly, the donated tissues were cut to small pieces 
and digested for 60 min at +37 °C water bath with shaker in a solution containing 1.5 mg/ml 
collagenase type I (Life Technologies, Thermo Fisher Scientific, Waltham, MA, USA) and 4 
mg/ml dispase (Invitrogen, Thermo Fisher Scientific) in Hanks’ balanced salt solution (HBSS, 
Life Technologies). Digested tissue pieces were filtered through 100 cell strainer (BD 
Biosciences, San Jose, CA, USA) and centrifuged. The tissue pieces and cell pellet were then 
cultured in separate T75 CellBind flasks (Sigma-Aldrich, St Louis, MO, USA) in EpiLife 
medium containing 1 % EpiLife Defined Growth Supplement (EDGS) (Gibco by Life 
Technologies, Thermo Fisher Scientific), 0.1 % calcium chloride (CaCl2) (Gibco by Life 
Technologies), 0.35 % antibiotics 100 U/ml penicillin and 0.1 mg/ml streptomycin (P/S; Lonza, 
BioWhittaker, Verviers, Belgium) in EpiLife® basal medium (Gibco by Life Technologies). 
To isolate the hVSCs, the primary culture was treated with TrypLE Select (Gibco by Life 
Technologies) for 2 min and cells passaged to T75 Nunc flasks (Nunc, Thermo Fisher 
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Scientific) in DMEM/F12 medium (Thermo Fisher Scientific) with 5 % human serum (HS) 
(Biowest, Nuaille´, France), 1% GlutaMAX (Life Technologies) and 1% of P/S (Lonza). Donor 
information is described in Table 1.  
Table 1 Donor information for hVSC cells used in Phase I of this study. 
Donor Study Passage Age Sex 
1 I 3 28 Female  
2 I 3 38  Female 
3 I 4 23 Female 
Prior the experiments, hVSCs were thawed and expanded on polystyrene T75 cm2 flasks 
(Nunc™ EasYFlask™, Roskilde, Denmark). Cells were cultured with αMEM culture medium 
containing 5 % sterile filtered HS (Biowest) and 1 % P/S in Minimum Essential Medium Eagle-
Alpha Modification (αMEM) (Gibco by Life Technologies). Culture medium was changed 
three times a week until cells were plated for experiment. 
4.2.2 Human urothelial cells 
Human UCs were isolated as described previously (Sartoneva et al., 2011; Southgate et al., 
2002) from ureter or renal pelvis tissue pieces, which were received as by-products from 
elective surgery from child patients. Briefly, tissue pieces were incubated overnight in +4 °C in 
a stripping solution containing 1 % HEPES (1 M, N′-2-hydroxyethylpiperazine-N′-2-
ethanesulphonic acid; Sigma-Aldrich), 0,0001 % aprotin (1 kIU/µl; Sigma-Aldrich), 0.1 % 
ethylenediaminetetraacetic acid (EDTA; Sigma-Aldrich), 0.01 % P/S (Lonza) in HBSS without 
Ca2+ and Mg2+ (Invitrogen). The epithelium layer was separated from the stroma and incubated 
for 60 min in 0.1 % trypsin (Lonza) in +37 °C water bath with shaker. Tissue pieces were then 
centrifuged and plated in Epilife growth medium on CellBIND T75 flasks (Sigma-Aldrich). 
Used hUC cell line donors are presented in Table 2. Corning™ CellBIND™ surface flasks 75 
cm2 (Sigma-Aldrich) were used for expansion hUCs cultured in Epilife medium. Culture 
medium was changed three times a week until cells were plated for experiment  
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Table 2 Information on the urothelium tissue donors and hUCs used in this study. General 
information on the donor and the sample origin are presented. M = used in monoculture, C = 
used in co-culture. 
Donor Study Passage Age Sex 
Anatomical 
place 
Indication 
1 II 
3 (M)  3 months 
 
Male Renal pelvis 
Pyeloureteral (PU) 
obstruction 4 (C) 
2 II 
3 (M)  2 years      
7 months 
Female Renal pelvis PU obstruction 
4 (C) 
3 
II 
 3 
  
2 years      
9 months 
Female Ureter 
Vesicoureteral 
reflux  
4.2.3 Human adipose derived stem cells 
Human ASCs were isolated as described previously (Haimi et al., 2009; Kyllönen et al., 2013) 
from fat tissue pieces derived from patients undergoing routine surgical procedures such as 
breast reduction. Briefly, the donated tissues were cut to small pieces and digested with 1.5 
mg/ml collagenase type I (Invitrogen) while incubating for 60 min at +37 °C water bath with 
shaker. Digested tissues were then centrifuged and filtered and expanded in DMEM/F12 
medium. Donor information of hASCs is described in Table 3.  
Table 3 Information on the adipose tissue donors and isolated hASCs used in this study. 
General information on the donor and the sample origin are presented. M = used in monoculture, 
C = used in co-culture. 
Donor Study Passage Age Sex 
Anatomical 
place 
1 II 
3 (M) 
62 years Male Abdomen 
4 (C) 
2 II 
3 (M) 
43 years  Female Subcutaneous 
4 (C) 
3 II 3 71 years    Female  Subcutaneous 
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Prior the experiments, the hASCs were thawed and expanded on polystyrene T75 cm2 flasks 
(Nunc™ EasYFlask™). Cells were cultured with αMEM culture medium containing 5 % sterile 
filtered HS (Biowest) and 1 % P/S (Lonza) in αMEM (Gibco by Life Technologies). Culture 
medium was changed three times a week and then cells were plated for experiment. 
4.2.4 Ethical consideration 
Cells used in this project were isolated from tissue samples received from Tampere University 
Hospital. The cells were isolated with the supportive statements of the Ethics Committee of 
Pirkanmaa Hospital District, Tampere, Finland: R07160 for hUCs, R15161 for hASCs and 
R15051 for hVSCs. Also written consent was obtained from the patients or parents in case of 
hUCs.  
4.2.5 Phase I: hVSC seeded PLCL membranes 
Phase II was carried out with three different hVSC cell lines. Membranes were placed to 24-
wellplates and fixed to the bottom of the well with CELLCROWN™ (Scaffdex Oy) and 
incubated in αMEM medium in +37 °C for 24 hours before cell seeding.  Cells were seeded in 
a concentration of approximately 5 000 cells/well, except for immunocytochemistry staining 
and Live/Dead® assay with concentration of approximately 7 000 cells/well. The cells were 
seeded on the membranes in a medium volume of 30 µl to the wells with 1 ml of 5 % HS in 
αMEM medium. 
4.2.6 Phase II: hUC and hASC monocultures and hUC/hASC co-culture  
Monocultures were conducted with hUCs and hASCs from three patients. Approximately 
150 000 cells were plated on the upper surface of 3D scPLCL scaffolds. Cells were seeded in a 
medium volume of 50 µl and let to attach for two hours in +37 °C before adding 1 ml of either 
Epilife for hUCs or 5 % HS in αMEM medium for hASCs. For polystyrene control wells (24-
well plate, Nunc, Roskilde, Denmark), 20 000 hUCs or 2 000 of hASCs were plated per well. 
Prior to the 3D scaffold co-culture study, different medium compositions were tested with hUC 
and hASC monocultures to optimize the medium composition for hUC/hASC co-culture. The 
tested medium compositions are presented in Table 4. The hUCs or hASCs from one donor 
were seeded on 24 well plate (Corning™ CellBIND™, Sigma-Aldrich) in five different 
medium compositions. Plating density for hASCs were approximately 2 000 cells/well and for 
hUCs approximately 20 000 cells/well. Cell viability, proliferation and morphology were 
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observed with Live/Dead® assay, CyQUANT® assay and light microscope (Nikon eclipse 
TE2000-S (Nikon, Tokyo, Japan) on d1, d7 and d14. Additionally, the pan-cytokeratin 
[AE1/AE3] expression of hUCs were determined on d14. The best performing medium was 
then selected to be used in hUC/hASC co-culture. 
The hUC/hASC co-culture was carried out in medium B (Table 4). Study was conducted with 
two different hASC and hUC cell lines. First, hASC were plated on other side of 3D scaffolds 
in concentration of 150 000 cells/scaffold. Human ASCs were cultured on scaffolds in 5 % HS 
in αMEM for five days in order to expand the amount of hASCs before plating hUCs to co-
culture. The scaffolds were turned upside down and hUCs plated on other side in concentration 
of 150 000 cells/scaffold. Simultaneously, the medium was changed to Epilife medium, the 
medium composition B, for hUC/hASC co-culture study (Table 4). 
Table 4 Tested co-culture mediums for hUC/hASC co-culture. Five different mediums 
including basic hASC medium (A) and hUC medium (B) and different combinations of these 
two were tested t be used in hUC/hASC co-culture in Phase II. 
A B C D E 
5 % HS 1 % EDGS 0.35 % P/S 1 % EDGS 1 % HS 
1 % P/S 0.1 % CaCl2 
in 1:1  
EpiLife:αMEM 
0.1 % CaCl2 1 % EDGS 
in αMEM  0.35 % P/S   0.35 % P/S 0.1 % CaCl2 
  in EpiLife    
in 1:1  
EpiLife:αMEM 
0.35 % P/S 
        
in 1:1  
EpiLife:αMEM 
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4.3 Used assays 
4.3.1 Cell morphology and viability (I, II): Live/Dead® 
Live/Dead® Viability/Cytotoxicity Kit for mammalian cells (Molecular probes, Invitrogen, 
Eugene, Oregon, USA) was used to determine the qualitative viability of the cells. Living cells 
transform calcein acetoxymethyl ester (Ca-AM) into fluorescent calcein intracellularly, staining 
them green. Ethidium homodimer-1 (EthD-1) can penetrate to dead cells due to their damaged 
cell membranes, and undergoes a modification when binding with nucleic acids, staining dead 
cells red in fluorescent imaging. (https://www.thermofisher.com/, 21.10.2018) Dye 
concentrations were determined by the scaffold used in cell culture. Used dye concentrations 
are presented in Table 5.  
Table 5 Dye concentrations in Live/Dead® assay. Concentrations of EthD-1 and Calcein-AM 
dyes in Live/Dead® assay vary in different phases of the study according to the used scaffold. 
Phase EthD-1 (µM) Calcein-AM (µM) 
I  PLCL membranes 0.3 0.25 
II  3D scPLCL scaffolds 3.75*10-5  0.5 
II  co-culture medium optimization 0.25 0.5 
Viability of hVSCs (I) was evaluated at d7 and d14 time points and the viability of hUCs and 
hASCs (II) at d1, d7 and d14 time points. Imaging was performed with Olympus IX51 
fluorescent microscope (IX51S8F-2, camera DP71; Olympus, Tokyo, Japan). Pictures were 
edited by combining colour channels with Adobe Photoshop CS4 (Version 11.0, Adobe 
Systems, San José, CAL, USA). 
4.3.2 Cell proliferation (I, II): CyQUANT® 
CyQUANT® Cell Proliferation Assay Kit (Molecular probes, Invitrogen, Eugene, Oregon, 
USA) was used to determine the proliferation of the cells by quantifying the amount of DNA 
present. CyQUANT® GR dye in working solution binds nucleic acids in the cells, creating 
fluorescence proportional to the amount of present DNA. The cell proliferation was evaluated 
after 1, 7, and 14 days of cell culture. At each time point, cells were first washed with 
Dulbecco’s Phosphate-buffered saline (DPBS; Lonza, BioWhittaker), lysed with 0.1 % Triton 
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x-100 (4-(1,1,3,3-tetramethylbutyl)phenyl-polyethylene glycol; Sigma Aldrich) and stored in -
80 °C until analysed. On the day of the analyse, thawed cell lysates were pipetted onto a 96-
MicroWell plate (Nunc, Roskilde, Denmark) 20 µl per well, with 180 µl of CyQUANT® 
working solution, containing cell lysis buffer (Life Technologies, Eugene, Oregon, USA) and 
CyQUANT® GR reagent (Life Technologies). The fluorescence in 480/520 nm was measured 
with Wallac Victor 1420 multilabel counter (PerkinElmer Life and Analytical Sciences, Wallac 
Oy, Turku, Finland).  
4.3.3 Immunocytochemistry (I, II) 
The indirect immunocytochemistry (ICC) staining was performed at d14 to visualize the 
specific antigens in sample. The samples were fixated with 0.2 % Triton x-100 (Sigma Aldrich) 
in 4 % PFA (paraformaldehyde; Sigma Aldrich) for 15 min in room temperature (RT). Prior to 
immunostaining, the fixated samples were blocked to avoid any unspecific binding. Samples 
were incubated for 60 min in +4 °C on a turner in a blocking solution of 1 % BSA (bovine 
serum albumin; Sigma) in DPBS (Lonza). The sample was treated with specific primary 
antibody for the selected antigen wanted to be visualized. The primary antibody was diluted in 
blocking solution and added on sample, incubating overnight in +4 °C on a turner. Next, the 
sample was treated with fluorescent-labelled secondary antibody, which binds to the primary 
antibody. Secondary antibody was diluted into blocking solution, and added on sample, 
incubating 45 min +4 °C on a turner. Cell nuclei were stained with fluorescent DAPI (4',6-
diamidino-2-phenylindole), to determine the cell localization. Used primary and secondary 
antibodies are presented in Table 6. The sample was then visualized with florescent imaging, 
where the fluorophore bound to secondary antibody and DAPI bound to cell nuclei emit light 
visualizing the antigen localization in sample. Simplified figure of the method is presented in 
Figure 12. Samples were imaged with fluorescence microscope (IX51S8F-2, camera DP71; 
Olympus, Tokyo, Japan). Pictures were edited by combining colour channels with Adobe 
Photoshop CS4 (Version 11.0, Adobe Systems). 
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Table 6 Information of used primary and secondary antibodies in immunocytochemistry 
staining.  
Primary 
antibody 
Manufacturer Reference Dilution 
Secondary 
antibody 
Dilution  
αSMA Abcam ab7817 1/200 A11029 1/300 
COL I Abcam ab90395 1/2000 A21121 1/400 
DAPI Invitrogen D3571 1/2000   
Pan-cytokeratin 
[AE1/AE3] 
Pierce MA5-13156 1/250 A21121 1/400 
Phalloidin Sigma P1951 1/500   
UPIIIA Orbyt orb248591 1/100 A11037 1/300 
 
 
 
 
Figure 12 The simplified visualization of indirect ICC detection of target antigens in a cell. 
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4.3.4 Sircol™ soluble collagen assay (I, II) 
The amount of produced collagen was assessed with Sircol™ soluble collagen assay kit 
(Biocolor, Carrickfergus, United Kingdom) after 14 days of cell culture. The assay measures 
acid-soluble and pepsin-soluble collagens and newly synthesised collagen 
(http://www.biocolor.co.uk/, 21.06.2018). Collagen was dyed with Sirius red in 1 % picric acid, 
and the produced absorbance was quantified with microplate reader. Samples were incubated 4 
hours in +4 °C with ice cold 0.1 mg/ml pepsin (Sigma Aldrich) in 0.5 M acetic acid. After 
incubation, 200 µl from each sample was moved to separate low protein binding Eppendorf 
tubes (Eppendorf AG, Hamburg, Germany). Collagen standard was prepared by diluting 
provided Sircol collagen standard with 0.5 M acetic acid to concentrations between 300 µg/ml 
and 0 µg/ml. Thereafter, 1 ml of Sircol Dye Reagent was added to each sample and standard 
tube, and incubated 30 min in RT. After incubation, the tubes were centrifuged 12 000 rpm for 
10 min, which after the supernatant was removed extra carefully. Thereafter, 750 µl ice-cold 
Sircol Acid-Salt Wash Reagent was gently added to all tubes, the samples were centrifuged 
again 12 000 rpm for 10 min and supernatant was carefully removed. Finally, 250 µl Sircol™ 
Alkali Reagent was added to each tube and vortexed until pellet was completely dissolved. Two 
parallel 100 µl samples were pipetted to 96 well-plate and measured absorbance with Wallac 
Victor 1420 multilabel counter (PerkinElmer Life and Analytical Sciences, Wallac Oy, Turku, 
Finland) with a wavelength 544 nm. 
4.3.5 Quantitative real time reverse transcription–polymerase chain reaction (I, 
II) 
The gene expression of specific genes was quantified with two-step quantitative real time 
reverse transcription–polymerase chain reaction (qRT-PCR). In qPCR the amplification of 
DNA is monitored simultaneously with the progression of the reaction. First, the RNA is 
purified from samples and transcripted to complementary DNA (cDNA). The cDNA is then 
used in the qRT-PCR run. In qRT-PCR, the template sequences of selected primers begin the 
gene sequence amplification by joining with the complementary target DNA sequences. During 
the thermal cycles of the run, the DNA strands denaturate at 95 °C and when temperature is 
lowered to 60 °C, the primers anneal with the target sequences. Then, when temperature is 
raised again, the polymerase enzyme elongates the sequence onward from the primers. These 
cycles are repeated to amplify the gene sequence (Figure 13). In real time PCR, the amount of 
produces DNA is monitored with fluorescent marker that binds to two-stranded DNA.  
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Figure 13 The main steps in qRT-PCR. Isolated sample RNA is first reverse transcripted to 
cDNA, which is then used in qRT-PCR, where thermal cycles regulate DNA amplification.  
To execute qRT-PCR, the RNA was first collected from the samples. The RNA was purified 
from samples according to Nucleospin® RNA-purification kit and protocol (Macherey-Nagel 
GmbH & Co. KG, Düren, Germany). Samples were collected on d14 by lysing the cells. Each 
sample was suspended with solution of 350 µl RA1 lysis buffer and 3.5 µl 2-mercaptoetanol 
(Sigma). The RNA was purified from the lysate by following the RNA purification protocol 
(Macherey-Nagel, 06/2015, Rev. 17). The attained RNA amount and quality were then 
determined with NanoDrop 2000 Spectrophotometer (Thermo Fisher Scientific). Which after, 
the RNA of the samples was diluted with sterile water (Aqua Sterilisata Braun, B. Braun, 
Melsungen, Germany) to a concentration of 100 ng/µl, or if the total ng/µl yield was lower, the 
samples were not diluted at all. Next, the RNA containing samples were transcripted to cDNA 
using the High-Capacity cDNA Reverse Transcriptase Kit (Applied Biosystems, Life 
Technologies). The reverse transcription was performed with Eppendorf PCR machine 
(Eppendorf, Hamburg, Germany) with a run program 25 °C 10 min, 37 °C 2 h, 85 °C 0,05 s.  
For qPCR run, the cDNA samples were diluted 1:1 with sterile water (B. Braun). Expression of 
collagen type I (COL I), collagen type III (COL III), αSMA and elastin for hVSCs (I) and 
hASCs (II), and expression of cytokeratins CK7, CK8 and CK19, uroplakins UPIa, UPIb and 
UPIII for hUCs (II) were analyzed. Housekeeping gene RPLP0 (large ribosomal protein P0) 
was used for the normalization of the results. The sequences of used PCR primers are presented 
in Table 7. 
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Table 7 DNA primers used in qRT-PCR. Primers were selected to assay the state of cellular 
ECM synthesis and cell phenotype. Primer forward (F) and reverse (R) sequences and 
manufacturer information is presented. 
Gene Forward and reverse sequences Manufacturer 
αSMA 
F: 5' – GAC AAT GGC TCT GGG CTC TGA AA – 3’ Metabion 
Oligomer R: 5' – ATG CCA TGT TCT ATC GGG TAC TT – 3’ 
CK7 
F: 5' – CAT CGA CAT CGC CAC CTA CC – 3' 
Metabion 
R: 5' – TAT TCA CGG CTC CCA CTC CA – 3' 
CK8 
F: 5' – CCA TGC CTC CAG CTA CAA AAC –3' 
Metabion 
R: 5' – AGC TGA GGT TTT ATT TTG GGA CC – 3' 
CK19 
F: 5' – ACT ACA CGA CCA TCC AGG AC – 3' 
Metabion 
R: 5' – GTC GAT CTG CAG GAC AAT CC – 3' 
COL I 
F: 5' – CCA GAA GAA CTG GTA CAT CAG CAA – 3' TAG Copenhagen 
A/S R: 5' – CGC CAT ACT CGA ACT GGA ATC – 3' 
COL III 
F: 5' – CAG CGG TTC TCC AGG CAA GG – 3' 
Oligomer 
R: 5' – CTC CAC TGA TCC CAG CAA TCC C – 3' 
Elastin 
F: 5' – GGT GCG GTG GTT CCT CAG CCT – 3' 
Metabion 
R: 5' – GGG CCT TGA GAT ACC CCA – 3' 
RPLP0 
F: 5' – AAT CTC CAG GGG CAC CAT T – 3’ 
Oligomer 
R: 5' – CGC TGG CTC CCA CTT TGT – 3’ 
UPIA 
F: 5' – GGC ATC TCC AGT TGT GGT GG – 3' 
Metabion 
R: 5' – GTC CTC CCA CCCTCT GTT TG – 3' 
UPIB 
F: 5' – AGT CAC CAA AAC CTG GCA CAG – 3' 
Metabion 
R: 5' – TGA TGG ACC ATT TAC GCC ACA – 3' 
UPIII 
F: 5' – TCA GTG CAA GAC ACC ACC AA – 3' 
Metabion 
R: 5' – GTC CTC CCA CCC TCT GTT TG – 3' 
For each measured gene, a standard was diluted with sterile water (B. Braun) to cDNA 
concentrations of 50 ng/µl, 5 ng/µl, 0.5 ng/µl, 0.05 ng/µl and 0.005 ng/µl to form the standard 
line. The cell type used to form the standard was selected to be a cell type most relevant for the 
studied gene. In Phase I, the hVSCs were used as a control for all studied genes. In Phase II, 
the hASCs were used as a control for RPLP0, COL I, COL III, αSMA, and elastin, and hUCs 
as a control for uroplakins and cytokeratins. Master mix solution contained Power SYBR Green 
PCR Master Mix (Thermo Fischer), 10 µM forward primer, 10 µM reverse primer and sterile 
water (B. Braun). The passive reference 6-carboxy-X-rhodamine (ROX) dye was used in the 
protocol to internally normalize the data during the reaction. For the qPCR run, 1 µl of standard 
and 2 µl of sample were pipetted with 14 µl master mix per well. The plastic covered measuring 
well plate was then run with ABI 7300 Real Time PCR System (Applied Biosystems, Thermo 
Fischer Scientific, USA). The used run had stages of 95 °C 10 min, 45 x (95 °C 15 s, 60 °C 1 
min), 95 °C 15 s, 60 °C 1 min, 95 °C 15 s. Collected data was then normalized to the expression 
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of housekeeping gene RPLP0. Data was collected with software 7300 System Sequence 
Detection Software (version 1.4.1, Life Technologies Corporation, Carlsbad, CA, U.S.). 
4.3.6 Scanning electron microscope imaging (II) 
SEM imaging was performed for one cell line of hUC and hASC monocultures at d1, d7 and 
d14 time points. Samples were imaged with Scanning Electron Microscope Zeiss ULTRAplus 
(Zeiss, Oberkochen, Germany) at former Department of Materials Science, Tampere University 
of Technology (Figure 14).  
On the time point, the samples were fixed with 5 % glutaraldehyde (Sigma Aldrich) in 0.1 M 
phosphate buffer (pH 7.4, Sigma Aldrich) for 48 hours in RT. After fixation, the scaffolds were 
rinsed with 1 x DPBS (Lonza) and stored in +4 °C in 1 x DPBS (Lonza) until further sample 
processing. The samples were dehydrated with ascending ethanol (EtOH) series and dried with 
hexamethyldisilane (HMDS) treatment prior to SEM imaging.  Samples were incubated for 15 
min at RT in ascending EtOH concentrations 50 %, 60 %, 70 %, 80 %, 90 % and 100 % EtOH. 
100 % EtOH incubation was repeated once. After EtOH series, the samples were moved to 1:2 
HMDS:100 % EtOH -solution for 20 min. The HMDS concentration was then raised to 2:1 
HMDS:100 % EtOH -solution and incubated 20 min. Finally, samples were incubated twice in 
100 % HMDS for 20 min before leaving all the HMDS to evaporate. Dried samples were 
sputtered with carbon coating. (https://research.jcu.edu.au/archive/enabling/aac/cairns-
aac/biological-sample-preparation-for-the-sem, 04.12.2018)  
 
Figure 14 The SEM used for imaging hUC and hASC scPLCL monoculture samples. 
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4.3.7 Statistical analysis 
The achieved quantitative results were analysed with IBM SPSS Statistics version 25 (IBM 
Corp., Armonk, NY, USA) to establish the statistical significance of the results. The 
quantitative data was analysed with Mann-Whitney test (two samples) or one-way ANOVA 
(three or more samples) with Bonferroni post-hoc test. Significance level of p < 0.05 was 
considered as significant and p < 0.01 as highly significant. 
  
46 
 
5 RESULTS 
5.1 Phase I: hVSC seeded PLCL membranes 
5.1.1 Viability and morphology of hVSCs 
The viability of hVSCs on PLCL membranes was determined with Live/Dead® assay on d7 
and d14 of cell culture. Live/Dead® staining demonstrates that majority of cells were viable 
(green fluorescence) cells in all tested materials (Figure 15) and hardly any dead cells (red 
fluorescence) were detected. 
 
Figure 15 Human VSC Live/Dead® assay. Images of Live/Dead® viability assay performed on d7 and 
d14 for hVSCs cultured on hPLCLas, PLCLas, hPLCL and control PS. Viable cells are stained green 
and dead cells red. Some background stain visible from membranes. Scale bar 500 µm. 
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On PLCLas membranes, the cells mostly appear to form a uniform cell layer with very few cell 
clusters, and clusters further diminishing from d7 to d14. On plain hPLCL, the cells form cell 
clusters and small cell layers on both d7 and d14. According to the Live/Dead® staining, the 
morphology of hVSCs on hPLCLas and PLCLas on d14 seem similar to cells on PS. Human 
VSCs seem to be more elongated the denser they grow. However, some rounder cells can be 
seen in areas with sparser cell layer on all materials. Yet, the cell clusters formed on membranes 
cannot be seen on the PS at all. Qualitatively, the hVSC cell number seems to be higher on 
hPLCLas and PLCLas -membranes than on hPLCL. 
5.1.2 Proliferation of hVSCs 
The proliferation of hVSCs was evaluated with quantitative CyQUANT® assay on d1, d7 and 
d14 time points. The results were normalized to d1 PS samples. The relative DNA contents are 
presented in Figure 16. 
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Figure 16 CyQUANT® proliferation assay of hVSCs. Relative DNA content of hVSCs 
membranes on d1, d7 and d14 of cell culture. * p < 0.05 ** p < 0.01. N = 6. 
On d1, slightly significant difference (p < 0.05) in DNA content between hPLCLas and hPLCL 
is seen. However, DNA content on PS is significantly higher than on any of the biomaterials 
tested (p < 0.001 on d1 and d7, and no statistical differences is detected between biomaterial 
membranes on d7. On d14, DNA amount on PS is significantly higher than on PLCLas and 
hPLCL (p < 0.01), yet not higher than on hPLCLas (p = 0.108). Further, DNA content on d14 
is significantly higher on hPLCLas than on hPLCL (p = 0.008). DNA amount significantly 
increased on hPLCLas and PLCLas between d7 and d14, p < 0.001 and p = 0.011 respectively, 
whereas no statistical difference could be detected on hPLCL. These proliferation assay results 
are in line with the qualitative results of viability assay. 
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5.1.3 Immunocytochemistry of hVSCs 
The ICC staining was used to determine the level of hVSC collagen production and 
myofibroblast differentiation along with the capability to maintain the myofibroblast phenotype 
on d14 (Figure 17). Immunostaining of COL I was used to visualize the differences in collagen 
synthesis. The αSMA was used as a marker for determining the myofibroblast in hVSCs 
cultured on different biomaterials.  
  
Figure 17 ICC of hVSCs. ICC stain of COL I and αSMA in hVSCs cultured on hPLCLas, 
PLCLas, hPLCL and PS samples on d14 of cell culture. Scale bar 200 µm. 
COL I production appears to be enhanced in PLCLas and hPLCLas membranes compared to 
hPLCL and PS. According to immunostaining, the hVSCs cultured on hPLCLas and PLCLas 
membranes secrete COL I fibres outside the cells, forming fibre-rich areas to ECM. The 
excreted collagen fibres also seem align in some level, especially on PLCLas. Stained COL I 
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spots are also visible inside the cells, where the collagen is being modified and not secreted yet. 
In hPLCL sample, the COL I still remains inside the cells going through last-stage 
modifications before secretion. It is visible how the collagen fills the cell in small grains, but 
no secreted fibres are visible in ECM. Viability of hVSCs on hPLCL seem very similar to PS 
control, where the COL I is also inside the cells and not yet matured enough to be secreted. 
Thus, the collagen maturation and production appear to be increased on hPLCLas and PLCLas 
compared to PLCL and PS.  
In αSMA immunostaining, the form of the actin fibres seems similar between the biomaterials 
and PS and no specific structural differences can be identified. Human VSCs on all materials 
maintained the myofibroblast phenotype. According to the qualitative assessment, the amount 
of αSMA on hPLCLas and PLCLas appears to be greater than on hPLCL, meaning more 
myofibroblasts are present. The amount of αSMA on hPLCLas seem very similar to PS. 
5.1.4 Quantitative analysis of hVSC collagen production 
The amount of total acid-soluble and pepsin-soluble collagen was quantified with Sircol™ 
Soluble Collagen Assay after 14 days of cell culture. The Figure 18 shows the total collagen 
concentrations in samples (µg/ml).  
The amount of produced collagen was significantly higher on hPLCLas and PS than on hPLCL 
(p < 0.01). No statistical significance was detected between PLCLas and hPLCL. However, 
when statistically analysing only the biomaterials and not taking PS into account, both hPLCLas 
and PLCLas had higher collagen amounts than hPLCL (p < 0.01).  
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Figure 18 Total amount of acid soluble and pepsin soluble collagen on d14 produced by hVSCs 
cultured on hPLCLas, PLCLas, hPLCL and PS materials.  ** = p < 0.01. N = 6. 
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5.1.5 Gene expression of hVSCs 
The relative gene expression of αSMA, COL I, COL III and elastin was evaluated on d14 with 
qRT-PCR. Results are first normalized to sample’s parallel RPLP0 result, which is then further 
normalized to PS control result individually inside each donor’s samples to achieve the relative 
expression compared to PS control. Averages of relative expression of the three donors’ 
samples are presented in Figure 19. Statistical analysis was not performed as the sample size N 
= 3 is too small for reliable statistical analysis. Nevertheless, the results show some reference 
to differences in gene expression between the materials. 
The relative expression of αSMA seems to be increased on AAD membranes compared to 
hPLCL but stay still under the level of PS control. Further, the relative expression of COL I and 
COL III seems to be increased on AAD membranes, even over the level of PS. This is in line 
with the results of Sircol™ and ICC results. The deviations in elastin results are quite large, but 
still it seems like the elastin expression is higher on biomaterials than on PS control. The results 
display increased elastin expression especially on holed membranes hPLCLas and hPLCL.  
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Figure 19 qRT-PCR results of hVSC culture. Relative gene expression of αSMA, COL I, COL 
III and elastin in hVSCs cultured on hPLCLas-, PLCLas-, hPLCL- membranes and PS control. 
N = 3. 
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5.1 Phase II: hUC monoculture on scPLCL scaffolds 
5.1.1 The hUC monoculture SEM imaging 
The attachment and morphology of hUCs were evaluated with SEM imaging on d1, d7 and d14 
of cell culture. 125 times magnification images from all time points and 500 times 
magnification images on d14 time points are shown in Figure 20. 
 
Figure 20 SEM images of hUC monoculture on scPLCLas and scPLCL scaffolds. 125x 
magnifications from time points d1, d7 and d14 are presented with single 500x magnification 
images from d14. Scale bar 100 µm. 
Cell attachment and morphology on d1 seems similar and well attached on both biomaterials 
and no striking difference can be seen. The cells are sparse but flattened along the material, 
preferring the pores of the scaffolds, as also seen in Live/Dead® assay. On d7 the cell number 
has increased considerably on both studied materials and the material surface seems to be 
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covered with cells. On scPLCLas, the hUCs surface seem smoother than on scPLCL. Whereas, 
the cell borders on scPLCL are more evident compared to scPLCL and the individual cells are 
easily distinguished at d7 and d14 time points. Further, small vesicles can be seen on the cell 
borders of the scPLCL.  
On d14, both biomaterial surfaces are covered with hUCs. When qualitatively evaluated, the 
cell number in scPLCLas appears higher than on scPLCL. In higher magnification, the hUCs 
on both scaffolds are cuboidal and flattened representing the morphology of urothelial cells and 
especially on scPLCLas, the hUCs have highly apparent cell borders.  On scPLCL hUCs seem 
flattened with visible nuclei. In Live/Dead® this difference could not be distinguished. Some 
round hUCs can be seen on both materials in all time points. 
5.1.2 Viability and morphology of hUCs in monoculture 
The viability of hUC monocultures on scPLCLas and scPLCL scaffolds was determined with 
Live/Dead® assay on d1, d7 and d14 of cell culture. Human UCs remained viable on both 
biomaterials. Qualitatively, the hUCs appeared to increase the cell number during the 
assessment period. No striking differences in cell number cannot be seen between the 
biomaterials with qualitatively inspection, and hardly any dead cells were visible (Figure 21). 
 
Figure 21 Live/Dead® assay of hUCs in monoculture on scPLCLas, scPLCL scaffolds and PS 
control on time points d1, d7 and d14 of cell culture. Scale bar 500 µm. 
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The hUCs preferred to grow in the scaffold pores on both biomaterials as visible in d1 images. 
However, the cells also seem to spread and grow on the smooth areas of the scaffolds. Based 
on qualitative evaluation, the cell amount seems to increase during the cell culture.  On PS 
control, the cells are roundish, whereas on the scaffolds hUCs seem to possess more epithelial-
like cuboidal morphology. Differences in hUC morphology between scPLCLas and scPLCL 
are not so evident. On scPLCLas the hUCs seem more elongated along the material surface on 
d14 with some cobblestone structure typical for epithelium. Whereas on scPLCL, the cells seem 
smaller and rounder with somewhat irregular appearance on d7 and d14.  
5.1.3 Cell proliferation in hUC monocultures 
The relative DNA content of hUCs was assessed with CyQUANT® on d1, d7 and d14 of cell 
culture time points with CyQUANT® assay. The results presented in Figure 22 are relative to 
scPLCL d1 DNA amounts. 
The DNA amount was significantly higher on scPLCL samples than scPLCLas in every time 
point. The difference was highly significant on d1 and d7 (p < 0.001) and significant on d14 (p 
< 0.05). No statistical difference in hUC DNA content between time points on scPLCLas could 
be detected. On scPLCL no significant difference was detected between d7 and d14, but 
between d1 and d14, DNA content had significantly increased (p < 0.001). The AAD seems to 
cause hUC proliferation to decrease compared to plain scPLCL. 
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Figure 22 CyQUANT® proliferation assay of hUC monoculture. The DNA amounts of hUC 
monocultures on scPLCLas and scPLCL relative to d1 scPLCL sample were quantified on d1, 
d7 and d14 of cell culture. * = p < 0.05, ** = p < 0.01, N = 9. 
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5.1.4 Collagen production of hUCs in monoculture 
The total amount of produced acid-soluble and pepsin-soluble collagen in hUC monoculture 
was determined with quantitative Sircol™ collagen assay on d14 time point. Sircol™ assay 
results are displayed in Figure 23. The amount of produced collagen was significantly higher 
on scPLCL samples than on scPLCLas (p < 0.01).  
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Figure 23 Sircol™ assay results of hUC monoculture. Total amount of acid-soluble and pepsin-
soluble collagen in hUC monocultures on scPLCLas and scPLCL scaffolds was measured on 
d14 time point. ** = p < 0.01, N = 9. 
5.1.5 Gene expression of hUCs in monoculture 
Relative gene expression of urothelial markers CK7, CK8, CK19, UPK1A, UPK1B and UPK3 
was quantified with qRT-PCR. Results from tested genes were normalized to sample’s parallel 
RPLP0 result and further to hUCs cultured on PS individually for each donor’s cells to achieve 
the relative expression to samples cultured on PS control. Statistical analysis was not performed 
as the sample size N = 3 is too small for reliable statistical analysis. Nevertheless, the results 
can display some tendency of differences in gene expression between samples (Figure 24). 
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Figure 24 Relative gene expression of CK7, CK8, CK19, UPK1A, UPK1B and UPK3 of hUCs 
in monoculture on scPLCLas, scPLCL -scaffolds and PS control was determined on d14 time 
point. N = 3. 
The amount of UPKIII was not detected reliably and thus excluded from the results. The 
standard deviations are large, and no exact conclusions can be made from the results. However, 
it seems like the CK 7 and CK8 expression is increased on scPLCLas scaffold compared to 
scPLCL and PS. Also, the relative expression of UPK1A seems to be higher on scPLCLas and 
scPLCL scaffolds than on PS control. Further, the expression of UPK1B seems decreased on 
scPLCLas and scPLCL scaffolds compared to PS. No apparent difference between materials is 
seen in the expression of CK19. 
5.2 Phase II: hASC monoculture on scPLCL scaffolds 
5.2.1 The SEM imaging of hASC monoculture 
The attachment and morphology of hASCs on scPLCLas and scPLCL -scaffolds were evaluated 
with SEM imaging on d1, d7 and d14. 125 times magnification from each time point is 
presented in Figure 25 along with single higher 500 times magnification on d14.  
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Figure 25 SEM images of hASC monocultures. SEM imaging was performed for hASC 
monocultures on scPLCLas and scPLCL scaffolds on d1, d7 and d14. 125x magnifications are 
presented from time points d1, d7 and d14, with additional 500x magnification image from d14 
from both materials. Scale bar 100 µm. 
On d1, the cells are attached both in pores and smooth scaffold surfaces on both materials and 
no striking difference in hASC number can be seen. Qualitatively on d7, there seems to be 
considerably greater amount of hASCs on scPLCLas, where the cells seem begin forming a 
dense cell sheet, whereas on scPLCL some small cell sheets along with cell clusters can be seen. 
On d14, the whole surface on scPLCLas is covered with hASC sheet. The sheet is smooth and 
covers the scaffold pores of the material. Some outlines of the pores can be seen underneath the 
cell sheet. On scPLCL, the cells seem to form loosely attached smaller sheets, but not as 
covering as in scPLCLas. Some larger cell clusters can also be seen apart from the cell sheets. 
In 500 times magnification on d14, the difference between scPLCLas and scPLCL is apparent. 
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Dense cell sheet is only visible on scPLCLas, yet on scPLCL loosely attached small cell sheets 
and dense clustered cell regions can be detected. 
5.2.2 Viability and morphology of hASCs in monoculture 
Viability of hASCs in monoculture on scPLCLas and scPLCL scaffolds was determined with 
Live/Dead® assay on time points d1, d7 and d14 of cell culture, PS served as a control. Majority 
of the hASCs remain viable on all materials (Figure 26). 
Although hASCs remain viable on all materials and no individual dead cells are visible, striking 
difference in hASC attachment and morphology can be seen between scPLCLas and scPLCL. 
Qualitatively inspecting, the cell number keeps increasing on scPLCLas from d1 to d14, 
forming dense cell sheet over the material, covering the scaffold pores. The increase in cell 
number between d1 and d7 is highly noticeable. hASCs on scPLCLas seem to have the same 
morphology as on the PS, but the cells seem to grow more densely.  
 
Figure 26 Viability assay images of hASC monoculture. Live/Dead® assay of hASCs in 
monoculture on scPLCLas, scPLCL scaffolds and PS control on time points d1, d7 and d14 of 
cell culture. Scale bar 500 µm. 
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On scPLCL, the cells form clusters and there seems to be some dead cells in the middle of the 
clusters, since the red hue is seen through the green surface of the hASC clusters. However, the 
surrounding cells in the clusters are viable.  The clusters do not seem to change in appearance 
between d7 and d14. Morphology of hASCs on scPLCL are very different from the hASCs on 
PS or scPLCLas. 
5.2.3 Cell proliferation of hASCs in monoculture 
The proliferation of hASCs in monocultures on scPLCLas and scPLCL scaffolds was assayed 
with quantification of relative DNA amount with CyQUANT® assay on time points d1, d7 and 
d14. Results are relative to hASC DNA amount on d1 on scPLCL. Normalized results are 
presented in Figure 27. 
On d1 the DNA contents were similar on both biomaterials and no significant difference was 
detected. The DNA content was significantly higher (p < 0.01) on scPLCLas scaffold on d7 and 
d14 compared to scPLCL. On scPLCL the DNA amount increased between the d1 and d7 (p < 
0.001) and d7 and d14 (p = 0.021). However, DNA content remained stable on scPLCL and no 
significant difference was visible between d1 and d7 (p = 0.180) or d7 and d14 (p = 0.962). 
Thus, the AAD in scPLCLas increased proliferation rate of hASCs. 
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Figure 27 Relative DNA amounts of hASC monocultures. The DNA amounts of hASC 
monocultures on scPLCLas and scPLCL relative to d1 scPLCL sample were quantified on d1, 
d7 and d14 of cell culture. * = p < 0.05, ** = p < 0.01. N = 9. 
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5.2.4 Collagen production in hASC monoculture 
The amount of hASC synthetized acid-soluble and pepsin-soluble collagen was measured with 
Sircol™ collagen assay on d14 on scPLCLas and scPLCL -scaffolds (Figure 28). The total 
amount of quantified acid-soluble and pepsin-soluble collagen in hASC monocultures was 
significantly higher (p < 0.01) scPLCLas scaffolds than on plain scPLCL.  
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Figure 28 Sircol™ assay of hASC monoculture. Total acid-soluble and pepsin-soluble collagen 
amount of hASC monocultures on scPLCLas and scPLCL scaffolds measured on d14 time point, 
** = p < 0.01. N = 9. 
5.2.5 Relative gene expression in hASC monocultures 
The relative gene expression of αSMA, COL I, COL III and elastin of hASC monocultures on 
scPLCLas and scPLCL was quantified on d14 with qRT-PCR. Results from tested genes were 
normalized to sample’s parallel RPLP0 result and further to hASCs cultured on PS individually 
for each donor’s cells to achieve the relative expression to samples cultured on PS control. 
Statistical analysis was not performed as the sample size N = 3 is too small for reliable statistical 
analysis. Nevertheless, the results can display some degree of differences in gene expression 
between samples (Figure 29). 
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Figure 29 Relative gene expression of αSMA, COL I, COL III and elastin of hASC 
monocultures cultured on scPLCLas and scPLCL -scaffolds, quantified on d14 of cell culture. 
Results are normalized to PS results. N = 3. 
The donor cell lines were very varying in their gene expression and thus the standard deviations 
are large. The expression of αSMA seems to be increased in scPLCLas scaffold compared to 
scPLCL, in which the expression seems decreased compared to PS control. No clear difference 
can be stated in relative expression of COL I. However, the expression of COL III seems 
increased on scPLCLas compared to scPLCL and PS. Relative expression of elastin seems 
higher on biomaterials than PS control, being higher on scPLCL than scPLCLas. 
5.3 Phase II: Medium optimization for hUC/hASC co-culture on scPLCL 
scaffolds 
5.3.1 Viability and morphology of hUCs and hASCs 
The viability of the hUCs and hASCs were determined with Live/Dead® staining on d7 and 
d14 time points. The contents of tested mediums are presented in Table 4. Medium A is the 
basic culture medium for hASCs, and B basic culture medium for hUCs, whereas mediums C, 
D and E are different combinations of these two.  
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The viability of hUCs was good in medium compositions B, C and D, but in mediums A and E, 
the cells were quite sparse, however, no dead cells are visible in any culture medium condition 
(Figure 30). The hUCs cell number does not seem to qualitatively increase in mediums A and 
E, the two mediums both with added HS.  Mediums B, C and D all have more present hUCs 
than A and E mediums. However, although the hUCs are viable and proliferating in mediums 
C and D, the hUC morphology does not resemble the morphology of hUCs in basic medium 
composition B. Some hUCs in B and D seem to swell and grow larger over cells attached to 
well bottom. 
 
Figure 30 Images from Live/Dead® viability assay performed on d7 and d14 time points for 
hUC cultured on five different cell culture medium conditions. A being the basic medium for 
hASCs and B the basic medium for hUCs. Rest mediums are combinations of A and B mediums. 
Detailed components are presented in Table 4. Green cells represent viable cells and red dead 
cells. Scale bar 500 µm. 
The hASCs remained viable in all medium compositions, but great variety in cell number can 
be seen (Figure 31). No dead cells are visible in any medium compositions. The basic hASC 
medium is the composition A, where the cell number seems to increase between d7 and d14. 
Whereas in mediums B, C and D the cell number seems not to increase noticeably when 
qualitatively inspecting. In medium composition A, the basic hASC culture medium, cells grow 
densely elongated. The hASC morphology in B, C and D mediums seem elongated, but cells 
are sparse. In medium E, the hASCs seem to grow densely but seem larger than in basic medium. 
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Figure 31 Images from Live/Dead® viability assay performed on d7 and d14 time points for 
hASCs cultured on five different cell culture medium conditions. A being the basic medium for 
hASCs and B the basic medium for hUCs. Rest of the mediums are combinations of A and Bs. 
Detailed components are presented in Table 4. Green cells represent viable cells and red dead 
cells. Scale bar 500 µm. 
As seen in Figures 30 and 31, hUCs and hASCs preferred opposite mediums, yet they remained 
viable in all medium conditions. However, there is differences is cell morphologies even when 
the cells seem to proliferate. 
5.3.2 The immunostaining of hUC cytokeratin structure 
Immunostaining of pan-cytokeratin [AE1/AE3] was performed on hUCs cultured in five 
different medium compositions (Table 4) on d14 time point, to assess changes in cytokeratin 
cytoskeleton structure (Figure 32). Medium B is the basic culture medium for hUCs, and A 
basic culture medium for hASCs, whereas mediums C, D and E are different combinations of 
these two. 
Human UCs in medium B, the basic hUC culture medium, present the normal hUC cytokeratin 
structure and the morphology of cells is normal to hUCs. The hUCs seem to be noticeably larger 
in presence of HS, as seen in the medium compositions A and E. In A (5 % HS), hUCs are large 
and individual keratins are visible. In E (1 % HS), hUCs are large and the keratin staining 
slightly resembles hUCs in B. However, the hUCs are abnormally large and grow clustered. In 
the mediums C and D, the cell borders are not detectable, and no individual cells can be 
distinguished. In majority of the cells in medium C, the pan-cytokeratin signal is not very 
intense and there are some small brightly stained hUCs among the cells. Qualitatively analysing 
the number of DAPI-stained nuclei, the cell amount seems to be higher in the medium 
composition C. Apart from medium B, the hUCs in do not resemble the typical cuboidal hUC 
morphology in any of the experimented medium compositions. 
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Figure 32 Immunofluorescence images of hUCs cultured in five different medium 
compositions A-E. A being the basic medium for hASCs and B the basic medium for hUCs. 
Rest of the mediums are combinations of A and B. Detailed components are presented in Table 
4. Pan-cytokeratin [AE1/AE3] marker (green) was used to stain the hUC cytokeratin structure. 
DAPI was used for nuclei staining (blue). Scale bar 100 µm. 
5.3.3 Cell proliferation of hUCs and hASCs 
Relative DNA content of hASCs and hUCs cultured in five different medium compositions 
(Table 4) was evaluated with CyQUANT® assay on d1, d7 and d14. Medium A is the basic 
culture medium for hASCs, and B basic culture medium for hUCs, whereas mediums C, D and 
E are different combinations of these two basic mediums. No statistical analysis was performed, 
because the sample size of N = 3 is too small for reliable statistical testing. The relative DNA 
contents of hUCs presented in Figure 33 are normalized to d1 hUCs samples cultured in 
medium B.  
The hUCs proliferated most in medium compositions B, C and D, and least in mediums A and 
E, as also seen in viability assay and in ICC staining. In medium A (5 % HS) the DNA amount 
seems to decrease during the assessment period, whereas in medium E (1 % HS) the cell number 
seems to remain steady. In absence of HS in mediums B, C and D, the cells proliferate rapidly 
in 7 days, but only slight increase is seen between d7 and d14. 
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Figure 33 Proliferation assay results of hUCs in medium testing. The relative DNA amount of 
hUCs cultured on five different medium compositions was quantified with CyQUANT® assay 
on d1, d7 and d14 of cell culture. N = 3. 
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The proliferation results were the very opposite for hASCs, where the hASCs were not 
proliferating in absence of HS. The relative DNA contents of hASCs presented in Figure 34 are 
normalized to d1 hASCs samples cultured in medium A. 
Human ASCs rapidly proliferate in mediums A and E between d1 and d7, and further slightly 
increase by d14. In mediums B and D, the DNA amount seems to increase slightly between d1 
and d7 and remain steady through to d14. In medium composition C, the hASC number does 
not change at all during the whole assessment period. 
HFSC Medium CQ
d1 d7 d1
4
0
10
20
30
40
50
A
B
C
D
E
R
e
la
ti
v
e
  
D
N
A
 c
o
n
te
n
t
 
Figure 34 Proliferation assay results of hASCs in medium testing. The relative DNA amount 
of hASCs cultured on five different medium compositions was quantified with CyQUANT® 
assay on d1, d7 and d14 of cell culture. N = 3. 
When considering the cell proliferation and viability results, medium composition B, the basic 
hUC culture medium, was selected to be used in further studies of hUC/hASC co-cultures. 
5.4 Phase II: hUC/hASC co-culture on scPLCL scaffolds 
5.4.1 Viability of cells in hUC/hASC co-culture 
Live/Dead® assay was performed for hUC/hASC co-cultures on scPLCLas and scPLCL 
scaffolds on d1, d7 and d14 time points to assess the viability of the hUCs and hASCs in co-
culture. The hASCs remained viable throughout the study on scPLCLas but formed cell clusters 
on scPLCL with visible dead cells, further diminishing towards d14 of co-culture (Figure 35). 
Even cell sheet of hASCs is visible on scPLCLas scaffold, but it is not spreading as robustly as 
seen in hASC monoculture (Figure 26). 
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Figure 35 Live/Dead® results of hASCs in co-culture. Viability of hASCs cultured in 
hUC/hASC co-culture on scPLCLas and scPLCL scaffolds was assayed on time points d1, d7 
and d14. Scale bar 500 µm. 
Human UCs remained viable throughout the study and seemed to increase cell number on both 
scPLCLas and scPLCL scaffolds when qualitatively inspecting (Figure 36). No dead cells are 
visible in any of the samples and the cells seem to prefer growing inside the pores of the scaffold 
in both biomaterials. 
 
Figure 36 Live/Dead® results of hUCs in co-culture. Viability of hUCs cultured in hUC/hASC 
co-culture on scPLCLas and scPLCL scaffolds was assayed on time points d1, d7 and d14. 
Scale bar 500 µm. 
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Both hASCs and hUCs remained viable in co-culture during the assessment period of 14 days. 
Human ASCs maintained viable better on scPLCLas scaffold, whereas no difference can be 
assessed in hUC viability by qualitative inspection. 
5.4.2 The immunostaining on hUC/hASC co-cultures 
ICC was performed for hUC/hASC co-cultures on scPLCLas and scPLCL scaffolds to 
determine the cell phenotype maintenance and hUC maturation on d14 time point. 
Immunostaining was conducted with two co-stainings. Co-staining of immunomarkers αSMA 
and UPK3A was performed to determine the myogenic capability of hASCs, and late 
maturation of hUCs, respectively. The immunostaining of αSMA and UPK3A of hASCs in co-
culture is presented in Figure 37. 
 
Figure 37 Immunofluorescence images of hASCs cultured in hUC/hASC co-culture on 
scPLCLas and scPLCL scaffolds and hASCs in PS monoculture. Myogenic marker αSMA 
(green) and urothelial maturation marker UPK3A (red) was stained on d14 of co-culture. Nuclei 
were stained with DAPI. Scale bar 200 µm. 
Human ASCs did show αSMA on both biomaterials, but the protein was more visible on 
scPLCLas scaffold than scPLCL scaffold. It seems like the hASCs on scPLCLas showed more 
αSMA than hASCs on scPLCL scaffold or plain PS. No UPK3Awas detected in hASCs in 
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hUC/hASC co-culture either on scPLCLas or scPLCL scaffolds, as expected. Immunofluores-
cence images of co-stain of αSMA and UPK3A in hUCs are presented in Figure 38. 
 
Figure 38 Immunofluorescence images of hUCs cultured in hUC/hASC co-culture on 
scPLCLas and scPLCL scaffolds and hUC monoculture on PS control. Myogenic marker 
αSMA (green) and urothelial maturation marker UPK3A (red) was stained on d14 of co-culture. 
Nuclei were stained with DAPI. Scale bar 100 µm. 
The hUCs in hUC/hASC co-culture expressed both αSMA and UPK3A markers. However, no 
noticeable difference in staining intensity is seen between scPLCLas and scPLCL scaffolds. 
Yet on plain PS, as a monoculture control, both αSMA and UPK3A signals seem to be weaker. 
Co-immunostaining of pan-cytokeratin [AE1/AE3], marker for phenotypic hUC cytokeratin 
profile, and phalloidin, F-actins of cytoskeleton, was also performed for hUC/hASC co-cultures 
on scPLCLas and scPLCL scaffolds on d14 time point. No cytokeratins were detected in hASC 
cells on either of the scaffolds (Figure 39). The hASCs have preserved their structure of actin 
cytoskeleton. The actins seem more structured and linear on scPLCLas samples, where on 
scPLCL the cytoskeleton is not as well organized. 
68 
 
 
Figure 39 ICC images of pan-cytokeratin [AE1/AE3] and F-actins in hASCs cultured in 
hUC/hASC co-culture. Pan-cytokeratin [AE1/AE3] (green) and F-actins with phalloidin (red) 
were stained on d14 of hUC/hASC co-culture on scPLCLas and scPLCL scaffolds and hASC 
monoculture on PS control. Nuclei were stained with DAPI. Scale bar 200 µm. 
The same co-staining of pan-cytokeratin [AE1/AE3] and phalloidin in hUCs showed that hUCs 
in hUC/hASC co-culture do maintain the hUC phenotype by expressing the hUC cytokeratin 
profile (Figure 40). Human UCs also have F-actins in their cytoskeleton. 
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Figure 40 ICC images of pan-cytokeratin [AE1/AE3] and F-actins in hUCs cultured in 
hUC/hASC co-culture. Expression of pan-cytokeratin [AE1/AE3] (green) and F-actins with 
phalloidin (red) were stained on d14 of hUC/hASC co-culture on scPLCLas and scPLCL 
scaffolds and hUC monoculture on PS control. Nuclei were stained with DAPI. Scale bar 200 
µm. 
No difference in hUC immunostainings of pan-cytokeratin or phalloidin is visible between the 
biomaterials or even the PS monoculture control. However, it seems like the hUCs on scPLCL 
seem more elongated and seem to less present the epithelial cuboidal morphology seen on 
scPLCLas and PS control. 
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6 DISCUSSION 
Pelvic floor and urethra are both elastic tissues that are subjected to various repetitive forces. 
Therefore, the scaffold material used in these applications needs to be flexible and able to 
withstand repeated stress. Due to these properties, PLCL has previously been studied for soft 
tissue engineering applications with promising results (Pangesty et al., 2017; Sartoneva et al., 
2018; Wu et al., 2016). Additionally, the permeability of PLCL to various drugs enables the 
addition various growth factors into the PLCL matrix (Nair & Laurencin, 2007). By embedding 
PLCL scaffolds with selected growth factors or nutrients, the tissue regeneration in vivo could 
be enhanced. Therefore, PLCL was selected as the scaffold material for this study. The aim of 
this study was to determine the effect of added AAD in PLCL scaffolds to different cell types. 
PLCL membranes were studied with hVSCs (I) and scPLCL scaffolds with hUCs and hASCs 
(II). Additionally, a suitable medium for hUC/hASC co-culture was tested and applied for hUC 
and hASC co-culture on scPLCL scaffolds (II). Cell viability and morphology was assessed 
with Live/Dead® assay (I, II) and SEM-imaging (II), cell proliferation quantified with 
CyQUANT® (I, II), relative gene expression with qRT-PCR (I, II), acid-soluble and pepsin-
soluble collagen amount measured with Sircol™ collagen assay, and localization of specific 
proteins visualized with ICC (I, II).  
6.1 Phase I: hVSC seeded PLCL membranes 
The ideal material for pelvic floor regeneration is still non-existent. The non-absorbable meshes 
have substantially high complication rates and therefore development of new biomaterials for 
reconstructive POP surgery is important (Medel et al., 2015; Osborn et al., 2013; Roman et al., 
2015). In this study, hVSCs cultured on PLCL membranes were studied aiming to regeneration 
of neofascia. The final aim is that the tissue engineered graft would enhance ECM production 
in vivo to restore the strength and support of pelvic floor fascia. This study revealed that the 
novel PLCLas membrane increased collagen production and supported the myofibroblast 
phenotype of the vaginal stromal cells.  
6.1.1 hVSCs remained viable and their proliferation was enhanced by AAD 
As observed with Live/Dead® assay, all studied PLCL membranes supported the cell viability 
and no dead cells were detected. The membranes with AAD seem to better support the cell 
attachment, as seen as more spread cell layer and absence of cell clusters. The hVSC attachment 
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seemed to be less ideal on hPLCL membranes. On hPLCL, cells formed cell clusters and 
seemed to prefer attachment with each other than the material, additionally, the hVSCs did not 
spread evenly on the material. Similar cluster forming was observed with hASCs on scPLCL 
scaffolds. Yet, on hPLCLas and PLCLas membranes, the cells formed large, even cell sheets 
along the material surface. The cells mainly shared the morphology of control cells, even though 
in more sparse regions the cells seemed larger and more rounded.  Cell number seemed to be 
higher on hPLCLas and PLCLas membranes compared to hPLCL.  This might be due to AAs 
proliferative effect on cells along with the incapability of the hVSCs to attach and spread on 
hPLCL. However, as PLCL is hydrophobic biomaterial (Webb et al., 1998), the poor attachment 
of hVSCs might be due to the PLCL material properties. By embedding hydrophobic PLCL 
with hydrophilic AAD, the scaffold hydrophilicity might be increased and thus the cell 
attachment is enhanced on hPLCLas and PLCLas (Webb et al., 1998; Zhao et al., 2014). In 
addition, the better cell attachment on PLCLas membranes might be due to the different 
material surface topologies present. Dissolving embedded AAD leaves behind surface 
irregularities that might in part enhance cell attachment. It was clearly visible that hVSCs prefer 
PLCLas membranes over plain hPLCL. Therefore, both hPLCLas and hPLCL membranes can 
be thought as suitable scaffolds for hVSC cell culture.  
The relative proliferation of hVSCs were quantified with CyQUANT® assay on d1, d7 and d14 
of cell culture. The PS control was the best out of all samples on every time point, yet between 
the biomaterials, hPLCLas and PLCLas had higher DNA contents than plain hPLCL membrane. 
The cell proliferation on hPLCLas and PLCLas seemed to speed up after 7 days of cell culture, 
with approximately fourfold increase in DNA amount on d14. The results are in line with 
Live/Dead® results. The added AAD thus seems to have significant role in increasing hVSC 
proliferation. Also, Saitoh et al. have showed that additional AA or its derivatives do increase 
cell proliferation even in senescence human fibroblasts (Saitoh et al., 2013). 
However, the hVSC proliferation did not reach the rate of PS control. This might due to the 
growth area differences. The growth area on biomaterials (~1.1 cm2) is smaller than the area of 
PS well (1.9 cm2), and the holes in holed membranes further increase the difference. 
Additionally, using CELLCROWN™ to hold the membranes further decreased the cell culture 
area. The free area for cell growth inside CELLCROWN™ is 0.58 cm2. So, the free growth 
area differs between the control and membranes, certainly affecting the proliferation results to 
some degree. Further, numerous cells escaped during cell seeding from the material surface to 
the well bottom, and thus were excluded from the performed analysis. Significant difference in 
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DNA content can be seen on d1 between biomaterials and control. This might be because the 
cells escaped through the membrane holes or under the CELLCROWN™ to well bottom. 
Letting cells attach for few hours before adding the medium, instead of seeding cells as droplets 
in to medium, might have been more appropriate to retain more cells on the membranes. 
However, this way the cells would not have been spread evenly on the membrane and therefore 
the droplet seeding method was selected. Alternatively, it might have been possible to include 
the cells from well bottoms to assays. However, this way the interaction between the cells and 
the material might not have been as clear. By studying only the hVSCs attached to the 
membrane, the results of cells interacting directly with the material could be examined. 
6.1.2 AAD increases collagen synthesis in hVSCs 
The fibroblastic metabolism of hVSCs was visualized with COL I marker, and myofibroblast 
phenotype with αSMA marker with ICC. The COL I synthesis appears to be enhanced in the 
presence of AAD in the scaffold. AA is essential in collagen synthesis and no collagen is 
excreted without AA (Arrigoni & De Tullio, 2002; Fernandes et al., 2009; Pozzer et al., 2017). 
As the cell culture medium already contains 50 mg/L AA 
(https://www.thermofisher.com/us/en/home/technical-resources/media-formulation.210.html, 
5.3.2019), the hVSCs on all membranes are capable of synthetizing collagen. However, with 
added AAD in hPLCLas and PLCLas, COL I is produced and secreted more rapidly than on 
plain hPLCL or PS control, where majority of the COL I is still going through post-translational 
modifications in ER before secretion. On the hPLCLas and PLCLas membranes, COL I forms 
large fibril bundles to ECM, with possibly some visible orientation, especially on PLCLas. 
Fibre alignment is essentially important for pelvic fascia, as it enables the tissue to withstand 
subjected forces without breaking. With weakened stress threshold, the fascia could break or 
loosen and lead to development of POP. (Roman et al., 2015; Ruiz-Zapata et al., 2016). 
However, specialized assays should be used for closer inspection on the collagen orientation 
and AAD’s effect to it. The increased amount of secreted collagen in presence of AAD is also 
seen in the results of Sircol™ assay. 
Amounts of acid-soluble and pepsin-soluble collagen were quantified with Sircol™ collagen 
assay. The synthesized collagen amount was lowest in hPLCL, supporting the results of COL I 
ICC assay. Total collagen amount was significantly higher on hPLCLas and PLCLas than on 
hPLCL (p < 0.001 and p < 0.05 respectively) when only taking into account the biomaterials in 
the statistical analysis. With PS control in the statistical analysis, no significant difference 
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between PLCLas and hPLCL was detected (p = 0.051). The lower amount of synthetized 
collagen on hPLCL is not explained with the presence of less cells, because even when 
considering the cell number, the amount of produced collagen is the lower on hPLCL (not 
shown here). However, the differences between novel PLCLas membranes and control were 
not as prominent in Sircol™ assay as in ICC staining. The Sircol™ assay takes into account all 
collagen types I-V, whereas in ICC only COL I was stained. Supporting both ICC and Sircol™ 
analysis, the results from qRT-PCR point towards increased relative gene expression of COL I 
and more visibly increased relative expression of COL III on hPLCLas and PLCLas membranes 
compared to hPLCL. Result is in agreement with previous studies, where AA has been shown 
to enhance collagen gene expression in fibroblasts (Kishimoto et al., 2012).  It has also been 
stated that AA enhances the stability of collagen mRNA, so in addition to increased gene 
transcription, it might also be that the mRNAs are more stable during the protein synthesis 
(Arrigoni & De Tullio, 2002; Pinnell, 1985).  
All three of the performed assays, qualitative ICC and quantitative Sircol™ and qRT-PCR 
present results in line with each other showing that AAD in PLCL scaffolds increases collagen 
production in hVSCs. Further, results are in agreement with previous studies stating that AA 
increases fibroblast collagen production (Boyera et al., 1998; Mangir et al., 2016; Piersma et 
al., 2017; Pinnell, 1985). In case of pelvic floor repair, the ratios of synthetized collagen types 
seem to be important for sufficient support capability and for the hVSCs proliferation. The ratio 
of COL I and COL III in a copolymer affects the biomechanical properties of the tissue (Peeters 
et al., 2014; Vashaghian et al., 2018). Increased amount of COL III leads to decreased fibre size 
and thus to lower strength. In turn, decreased COL III amount causes increased stiffness of the 
tissue. (Alperin & Moalli, 2006; Peeters et al., 2014; Zhou et al., 2012) Zhou et al. observed 
decrease in quantified COL III amount in POP patients and that the vaginal tissue was stiffer 
compared to controls, but they did not detect change in COL I amount (Zhou et al., 2012). In a 
study by Hung et al., the cell culture of POP-patient-derived hVSCs with higher COL I/COL 
III ratios achieved significantly higher cell proliferation rate than those with lower COL I/COL 
III ratios (Hung et al., 2010). Further, mechanical stimulation of hVSC culture lead to increased 
COL I/COL III ratio in a study by Vashaghian et al. (Vashaghian et al., 2018). Thus, study on 
the effect of AAD on the collagen types synthetized should be considered and more closely 
inspected in upcoming studies. Moreover, in further experiments of hPLCLas and PLCLas 
membranes, the addition of strain would be important to further investigate the effect on the 
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mechanical properties of the formed fascia, when considering the clinical applications for pelvic 
floor repair.  
However, the relative expression of elastin seems not to be increased with addition of AAD 
into the scaffold, yet the expression levels are higher on biomaterials than on PS control, being 
highest on hPLCL. This result is in line with the findings of studies with human keratinocytes 
and fibroblasts showing that AA increases collagen synthesis but in turn decreases elastin 
synthesis (Pullar et al., 2017). Yet in aortic smooth muscle cells, AA has been shown to increase 
elastin expression (Okada et al., 2013). Further, AA has been shown to destabilize elastin 
mRNA during synthesis (Arrigoni & De Tullio, 2002). However, elastin production is activated 
later into the ECM remodelling and is rather stable during one’s life time (Alperin & Moalli, 
2006; Klutke et al., 2008; Ribeiro-Filho & Sievert, 2015) Many cell types have poor capabilities 
for elastin synthesis (Ribeiro-Filho & Sievert, 2015), though in vaginal tissues the elastin 
synthesis is important due to the changes subjected from pregnancy and vaginal delivery 
(Alperin & Moalli, 2006; Klutke et al., 2008). It might be that the assessment period of two 
weeks is not enough to see the induced changes in elastin synthesis. Increased elastin synthesis 
would be the desired outcome when considering pelvic floor applications, as abnormal elastin 
metabolism is associated with POP and UI (Alperin & Moalli, 2006; Chapple et al., 2015; 
Klutke et al., 2008; Ribeiro-Filho & Sievert, 2015). 
Human VSC myofibroblastic phenotype was assayed by ICC staining of αSMA marker (Jones 
& Ehrlich, 2011; Piersma et al., 2017). Plenty of αSMA was visible on hPLCLas and PLCLas 
membranes, along with the PS control. Some αSMA was also present on plain hPLCL. However, 
as seen also in viability and proliferation assays, the cell number on hPLCL is significantly 
lower, and thus the decreased presence of myofibroblasts might also be due to a lower number 
of cells compared to other biomaterials, and not solely as a result of the effect of AAD. However, 
qRT-PCR results of αSMA expression show slight increase on hPLCLas and PLCLas 
membranes, pointing towards the effect of AAD in the membranes. Fibroblast differentiation 
to myofibroblasts is controlled by TGF-β1 (Hinz et al., 2001; Ruiz-Zapata et al., 2016; Sun et 
al., 2016). AA appears to increase TGF-β1 production and thus induce higher rate of 
myofibroblast differentiation (Lee et al., 2013; Piersma et al., 2017). Fibroblasts have been 
shown to transiently differentiate to myofibroblasts when ECM needs to be repaired or 
reorganized (Ruiz-Zapata et al., 2016). Thus, enhancing presence of myofibroblasts could lead 
to more effective ECM regeneration in vivo.  In future, gentle strain could be added for the 
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hVSC in vitro culture, as it has been shown to increase ECM remodelling and accumulation 
(Gray et al., 2005; Roman et al., 2014; Vashaghian et al., 2018).  
The findings of this study are valuable for fascial tissue engineering, as women suffering from 
POP have significantly reduced collagen content in their endopelvic fascia when compared to 
healthy women (Alperin & Moalli, 2006; Mangir et al., 2016; Zhou et al., 2012) and also altered 
elastin synthesis (Alperin & Moalli, 2006; Chapple et al., 2015; Klutke et al., 2008). By being 
able to induce increased collagen and elastin production, the generation of neofascia could be 
enhanced. However, as AA seems to increase collagen production and myofibroblasts 
differentiation, excessive amount of AA could lead to harmful fibrosis, rather that tissue 
regeneration on site (Piersma et al., 2017). Therefore, the rate of ECM synthesis should be 
increased only to the rate where it stays under control and does not lead to excessive fibrosis. 
6.2 Phase II: hUC and hASC monocultures on scPLCL scaffolds 
The first aim of the Phase II was to determine the effect of AAD in scPLCL scaffolds to hASCs 
and hUCs in monocultures. Human UCs are tested to determine the suitability of the scPLCLas 
and scPLCL scaffolds for regenerating mature urothelium, and hASCs to enhance to 
regeneration of vasculature and SMC layers of the urethra. The effect of AAD on cell viability, 
morphology, collagen synthesis and cell proliferation were investigated by performing 
Live/Dead®, CyQUANT®, Sircol™ and qRT-PCR analyses along with SEM-imaging. No PS 
could be used as control for scPLCL scaffolds since, the two-dimensional PS well bottom is 
not the ideal control material for 3D biomaterial studies. Therefore, PS control was excluded 
from the quantitative analyses performed for scPLCL scaffolds.  
6.2.1 Effect of AAD to hUC and hASC viability, morphology and proliferation 
Viability of hUCs and hASCs in monocultures were evaluated with Live/Dead® assay. Human 
UCs remained viable on all materials. The hUCs seem to be more rounded and smaller, with 
some grainy appearance on scPLCL compared to scPLCLas, as also seen in the higher 
magnification image in Figure 41. On scPLCLas some elongated well-attached hUCs can be 
seen.  
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Figure 41 Higher magnification of the hUC monoculture Live/Dead® assay on d14 on 
scPLCLas and scPLCL scaffolds. More flattened and elongated cells could be seen on 
scPLCLas scaffolds, whereas on scPLCL there were smaller cells with some vesicle-like 
particles. Scale bar 200 µm. 
Qualitatively, no distinct difference in cell number could be seen. However, in CyQUANT® 
proliferation assay, it is visible that hUCs proliferated significantly more on scPLCL scaffold. 
Such a difference in cell number was not strikingly visible in Live/Dead® assay or SEM 
imaging. It seems like the presence of AAD reduces hUC proliferation, but enhances the 
proliferation of fibroblastic cells, shown with hVSCs. This reduction in hUC cell proliferation 
might be due to the fact that AA can be inhibiting cell growth in excessive concentrations in 
the cell culture medium (Choi et al., 2008). The AA concentration in plasma is kept at 50 µM, 
and 1-10 mM inside cells (D’Aniello et al., 2017). The human AA intake from nutrition mainly 
takes place in small intestine enterocytes and renal cells (Du et al., 2012). The AAD released 
from scPLCLas scaffold could possibly raise the AAD concentration in the culture medium to 
too high levels for hUCs to withstand, which could then lead to decreased proliferation rate. 
SEM-imaging was performed for closer inspection of the hUC morphology. The hUCs formed 
even cell layer along the material surface on both materials. Human UCs on both biomaterials 
on d7 seem to have visible cell borders. On d14 the cells on scPLCLas seem to maintain similar 
morphology to d7, whereas on scPLCL the apparent cell borders diminish between d7 and d14 
and hUCs seem very flat on d14. When inspecting the 500 times magnification images, the 
hUCs on scPLCLas seem almost hexagonal with some vesicles on the cell borders. Hexagonal 
shape is seen in mature urothelium also (Cattan et al., 2011; Khandelwal et al., 2009). Some 
cells seem to have acquired more irregular cell surface, appearing as darker cells in the images. 
This might be due to the presence of microvilli or microridges on the hUC apical membrane, 
which could be a sign of maturation and presence of AUMs (Cattan et al., 2011). According to 
SEM-images, the hUCs are able to maintain their morphology during the assessment period on 
both scaffolds, however, on scPLCL the morphology seems flatter and smoother compared to 
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scPLCLas. However, no consistent differences between biomaterials visible in both 
Live/Dead® and SEM can be stated. Nevertheless, the AAD seems to have effect on the hUC 
morphology but defining the exact change would need closer inspection and further research 
on the matter.   
For hASCs the AAD was strikingly effective. The high cell proliferation on scPLCLas was 
visible in CyQUANT® assay, Live/Dead® assay and SEM images. Proliferation assay results 
show increase in hASC proliferation on scPLCLas scaffold compared to scPLCL. With added 
AAD, hASCs significantly proliferated between each time point, whereas DNA amount on 
plain scPLCL remained stable during the assessment period.  Additionally, both SEM and 
viability images (Live/Dead® assay) strongly support the results of the quantitative assessment. 
Even cell sheet is formed over the pores of the scaffolds on scPLCLas, whereas on scPLCL the 
hASC seem not to be able to attach properly and form cell clusters, similar to those seen with 
hVSCs in Phase I. On scPLCLas scaffold, hASCs are growing densely and have elongated 
morphology. Whereas on plain PLCL the hASCs remain relatively large, not stretching along 
the scaffold surface. Similarly, as in Phase I, the AAD embedded in PLCL might enable better 
cell attachment by increasing scaffold hydrophilicity. Additionally, the pores left behind from 
the dissolving AAD might further support the attachment of hASCs, forming irregularities to 
material surface. Obtained results are in line with existing literature; AA and its derivatives 
have been proven to increase hMSC proliferation rate in numerous studies (Choi et al., 2008; 
Fernandes et al., 2009; Saitoh et al., 2013; Weiser et al., 2009). Fernandes et al. showed that 
proliferation of hMSCs was impaired without endogenous collagen synthesis resulting from 
absence of AA (Fernandes et al., 2009). So, while increasing collagen production, AA 
simultaneously enhances hMSC cell proliferation. In a study by Lee et al. they showed that 
ASCs efficiently utilized supplemented AA. The serum concentrations of AA decreased in the 
presence of ASCs transplanted into mice. (Lee et al., 2013) ASCs therefore seem to be effective 
in AA uptake and utilizing, and thus have rapid effects in their cellular function. However, the 
proliferation rate cannot be indefinitely increased by increasing AA concentrations. 
Concentrations over 500 mM are shown to decrease proliferation rate of hMSCs (Choi et al., 
2008; Saitoh et al., 2013; Sato et al., 2017). The hASCs visibly preferred scPLCLas scaffold 
over scPLCL scaffold, and the released AAD significantly increased their proliferation. 
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6.2.2 AAD enhances hASC collagen synthesis, but decreases it in hUCs 
Collagen production in hUC and hASC monocultures on scPLCLas and scPLCL scaffolds was 
quantified with Sircol™ assay. Human UC collagen production was significantly lower on 
scPLCLas scaffold than on scPLCL. As collagen is mainly produced by fibroblastic cells, no 
high collagen amounts were expected from hUC cells. However, presence of AAD further 
decreased the collagen synthesis in hUCs.  
In turn, collagen synthesis of hASCs was significantly increased on scPLCLas scaffolds 
compared to plain scPLCL. Increased hASC collagen synthesis with addition of AA derivate 
has also been shown in earlier studies (D’Aniello et al., 2017; Yu et al., 2014). However, the 
qRT-PCR results for COL I and COL III, show only slight differences between the biomaterials. 
Expression of COL I on scPLCLas seems to be slightly lower, whereas COL III expression 
seems higher than on scPLCL. However, as the standard deviations are so large, no clear 
conclusions can be made about the effect of AAD on COL I or COL III relative expressions. 
Similar observation can be made from the results of relative expression of αSMA and elastin. 
Expression of αSMA seems to be slightly increased on scPLCLas and expression of elastin 
seems higher on biomaterials than PS control, but because of the high standard deviations no 
certain conclusion can be made. Previously, elastin production has been enhanced by AA in 
muscle cells (Okada et al., 2013). 
The qRT-PCR results for hUCs show that cells on both biomaterials express CK7, CK8 and 
CK19, the cytokeratins expressed in all urothelium cell layers (Khandelwal et al., 2009; 
Southgate et al., 1999). Further, the qRT-PCR results show slight increase in relative expression 
of UPK1A, with large standard deviations, and slight decrease in UPK1B expression on both 
biomaterials compared to PS. The UPK1B is critical for AUM plaque formations. Cuaresma et 
al. showed that in UPK1B knock-out mice, no functional formation of AUMs was detected 
(Cuaresma et al., 2015). Therefore, observed decrease of UPK1B expression would decrease 
the maturation of hUCs. Further, no UPKIII expression was detected but only in the strongest 
concentration of qRT-PCR run standard (not shown here), and thus the results were discarded 
from further analysis. 
6.3 Phase II: hUC/hASC co-culture on scPLCL scaffolds 
Human UC/hASC co-cultures on scPLCL scaffolds were performed aiming to regenerate 
functional urothelium and SMC layer differentiated from hASCs on opposite sides of 3D 
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scaffold, to mimic the urethral histological layers. Cell viability and phenotype were determined 
by Live/Dead® assay and immunological staining. In addition to hASCs capability to 
differentiate into myogenic lineage, MSCs secrete growth factors and cytokines on site, 
regulating tissue regeneration and injury repair. Human ASCs participate into tissue healing in 
vivo by recruiting endogenous stem cells and regulating their differentiation, along with 
secreting antioxidants and immunosuppressive molecules. Furthermore, hASCs produce 
cytokines inducing vasculature formation, guiding the formation of neovasculature to 
regenerating tissue. (Sterodimas et al., 2010) Therefore, in addition to providing alternative cell 
source for SMCs, hASCs would mediate inflammation and tissue healing in vivo, enhancing 
urethral regeneration (Gimble et al., 2007).  
6.3.1 hUC/hASC co-culture medium optimization 
The appropriate co-culture medium composition was tested individually for hUC and hASC 
monocultures prior to co-culture. Cells were cultured in five different medium compositions 
for two weeks, and their viability and proliferation were evaluated. Additionally, hUCs were 
stained with pan-cytokeratin [AE1/AE3] to assess medium’s effect on hUC cytokeratin 
structure. The hUCs and hASCs preferred almost strictly the opposite mediums tested. Human 
UCs could not withstand any HS in the medium and diminished even with 1 % HS concentration 
in medium composition E. The normal UC culture medium contains growth supplements and 
hormones for maintaining epithelial phenotype. However, the hUCs proliferated even without 
any supplements at all in medium composition C, which only contained 1:1 EpiLife and αMEM 
basal mediums, so HS seems to be inhibiting hUC proliferation. This could be due to the fact 
that hUC are not supposed to be in contact with blood serum in situ, but to filtrate components 
from diffusing from urea to blood circulation. Therefore, coming into contact with HS might 
disturb hUC proliferation. Similar results were found with lung epithelial cells by Lau et al., 
where HS induced apoptosis of the epithelial cells but no such response was observed when in 
contact with fetal bovine serum (FBS) (Lau et al., 2006).   
When further inspecting the effects of tested medium compositions to hUC cytokeratin 
phenotype by ICC, the results are consistent with the viability assay results. No normal hUC 
morphology was achieved in any of the tested medium compositions apart from medium B, the 
basic hUC culture medium.  
According to Live/Dead® results, hASCs suffered clearly without HS in the medium as is seen 
in the Live/Dead© results of medium compositions B, C and D. The cells have remained viable, 
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but the cell number seems not noticeably increased. However very slight increase can be 
detected in B and D mediums, both with epithelial growth supplements. The less suitable 
medium compositions for hASCs therefore seems to be medium C, which only contains basal 
mediums without additives. It seems like even concentration of 1 % HS maintains hASC 
proliferation, but slight increase is also possible with epithelial supporting supplements.  
In previous UC/SMC co-culture studies, medium has been composed of 1:1 keratinocyte serum-
free medium:DMEM medium (Liu et al., 2009; Wu et al., 2011). However, the 1:1 
Epilife:αMEM culture mediums containing medium composition D was not sufficient for both 
hUCs and hASC in this performed co-culture medium test. The priority for hUC/hASC co-
culture was set to achieve viable and phenotypic hUCs, so the co-culture medium was selected 
to be the basic hUC medium, the medium composition B. Human ASC cells also remained 
viable in medium composition B and appeared to slightly increase in number during the 
assessment period. Therefore, medium composition B was selected for the further experiments.  
6.3.2 Cells remain viable in hUC/hASC co-culture on scPLCL scaffolds 
The viability of cells was determined with Live/Dead® assay. Both cells remained viable in co-
culture. The viability assay results seem very similar to those seen in monoculture studies, 
especially in case of hUCs. Human UCs remain viable on both scaffolds and preferred to grow 
on the pores of the scaffold. It also seems like the cells on scPLCL are smaller than the hUCs 
on scPLCLas, similarly as in hUC monoculture. However, the hASCs did not form large cell 
sheet over the scPLCLas scaffold as they did in hASC monoculture. Human ASCs on scPLCLas 
did not seem to increase in cell number after the co-culture was initiated, but also did not die 
during the assessment period. Further, the hASCs on scPLCL initially form cell clusters like 
those seen in monoculture. Yet, during the 14-day co-culture period, the cell clusters seem to 
disappear and barely anything is visible on d14. It seems like the hASCs need the AAD in the 
scaffold to survive in the tested co-culture medium. Even though AA and its derivatives are 
shown to increase hMSC proliferation (Choi et al., 2008; Fernandes et al., 2009; Saitoh et al., 
2013; Weiser et al., 2009), it seems likely that the selected medium is not ideal for supporting 
hASC growth in hUC/hASC co-culture. Further medium optimization is therefore needed for 
upcoming experiments.  
In fluorescence imaging assays of Live/Dead® and ICC, the hUCs stained more intensively 
than hASCs, which interfered with imaging of hASCs, even though the cells were on opposite 
sides of the scaffold. Human ASC sheets spreading over scaffold pores were somewhat visible 
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on the microscope, but as the staining was so dim it was difficult to capture. Dead hASCs are 
much more visible than the live cells, as the EthD-1 signal was more intense than the Ca-AM 
in viable cells. The imaging could have been easier if the scaffold was halved for imaging. 
However, this would be very difficult to perform without seriously damaging the cells on the 
scaffold surfaces. Some other method should be considered for further experiments.  
6.3.3 Cell phenotypes in hUC/hASC co-culture 
State of hUC and hASC phenotypes was determined by ICC staining of specific markers. Co-
staining of αSMA and UPK3A was performed to assess the hASC myogenic capability and late 
maturation status of hUCs. Human ASCs did express SMC marker αSMA on both biomaterials, 
as revealed by ICC staining, illustrating their potential to differentiate towards SMCs (Lee et 
al., 2006). The amount of αSMA seems to be higher on scPLCLas than on plain scPLCL. Yet, 
as seen in Live/Dead® assay, the number of hASCs is lower on scPLCL, and therefore the 
difference seems likely to be due to the reduced number of cells. However, addition of β-
mercaptoethanol and AA to hASC culture has been shown to slightly increase αSMA 
expression (Lee et al., 2006). No UPK3A expression was detected in hASCs, which was 
expected, as it is a late UC maturation marker (Khandelwal et al., 2009). 
Surprisingly, αSMA was also visible in hUCs along with expression of UPK3A. Alpha SMA 
is a mesenchymal marker and is not therefore expected to be found in epithelial cells. UCs have 
been shown to express αSMA when going through epithelial-mesenchymal transition (EMT) 
(Foreman et al., 2015; Islam et al., 2013). TGF-β1 has been stated as one EMT inducer (Islam 
et al., 2013; Kasai et al., 2005). Lee et al. showed that AA upregulated TGF-β1 production in 
muscle cells (Lee et al., 2013). As a speculation, AA could affect similarly to ASCs and increase 
their TGF-β1 production, which then could possibly induce EMT in UCs in the co-culture. 
However, the exact phenotype of isolated primary hUCs has not been assayed, so it might be 
that amongst the achieved cells might be urothelial progenitor cells capable for differentiating 
to various cell types. These urothelial stem cells have been suggested to reside amongst the 
basal cells of the urothelium (Hickling et al., 2015; Ho et al., 2012). It might be that the early 
SMC marker αSMA could be slightly expressed in these cells in some point before committing 
to epithelial lineage. To determine whether or not hUCs are undergoing EMT in future 
hUC/hASC co-cultures, changes to epithelial markers such as claudins and tight junctions 
(Khandelwal et al., 2009), and additional mesenchymal markers in addition to αSMA, should 
be assessed to determine whether or not the epithelial phenotype is changing in hUCs. 
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Simultaneous expression of mesenchymal marker and hUC late-maturation marker UPK3A 
seems unlikely, but currently the explanation for achieving result like this remains unspecified 
and needs further studies on the matter. Staining could be done for histological urothelium 
sample to determine whether the used αSMA antibody would be expressed in mature 
urothelium. This would reveal the possible unspecific binding of the antibody. Similar test 
could be also performed for UPK3A. Alternatively, other antibodies binding to different region 
of the αSMA or UPK3A protein could be tested to confirm the positive result. 
The second co-staining of pan-cytokeratin [AE1/AE3] and phalloidin was conducted to 
determine whether hASCs have preserved their F-actin cytoskeleton and if the hUCs still 
express the hUC cytokeratin profile. Human ASCs did not express any of the cytokeratins in 
hUCs’ cytokeratin profile but seem to have maintained their actin cytoskeleton, with more 
normal organization visible on scPLCLas scaffold. On scPLCL, the hASC actin cytoskeleton 
seem more disorganized. Human ASCs do not maintain their normal morphology as also seen 
in viability assay both in co-culture and monoculture, and therefore the cytoskeleton is expected 
to be altered. Pan-cytokeratin was expressed in hUCs on both biomaterials, showing that they 
have maintained their hUC phenotype. Human UCs also stained for F-actins on the cell borders, 
staining the cortical actin cytoskeleton (Khandelwal et al., 2009). 
As the aim of the hUC/hASC co-culture was also to evaluate how the cells maturate and 
maintain their phenotype in co-culture conditions. This study showed that hASCs maintained 
their potential to myogenic differentiation, so in future experiments it is essential to optimize 
the hASC niche to guide differentiation towards SMC phenotype in vitro and in vivo. The 
scPLCLas seems promising material for performing hUC/hASC co-cultures for urethral tissue 
engineering, but the used co-culture conditions still need to be optimized to maintain 
phenotypes and viability in both cell types. 
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7 CONCLUSION 
Aim of this study was to analyse the effect of AAD embedded in PLCL scaffolds on hVSCs, 
hUCs and hASCs and hUC/hASC co-culture. AAD seems the enhance ECM production and 
proliferation of mesenchymal cells but does not affect similarly on hUCs. The main conclusions 
obtained from this research are: 
I. AAD significantly increased hVSC proliferation and collagen production. Gene 
expression of COL I and COL III also seem increased in PLCL membranes 
embedded with AAD, however, no increase in elastin expression was detected. In 
AAD embedded membranes, more myofibroblasts were present in ICC assay of 
αSMA marker, along with increased gene expression of αSMA. Obtained results 
show that added AAD is beneficial for hVSCs and that both hPLCLas and PLCLas 
show promising results considering pelvic floor tissue engineering applications. 
 
II. AAD significantly increased hASC proliferation and collagen production, but in 
turn significantly decreased them in hUCs. Relative expression of αSMA and COL 
III were enhanced with addition of AAD into scaffold. ScPLCLas scaffold thus 
seems beneficial for hASC culture for soft tissue engineering applications. Human 
UCs maintained their viability and morphology on both scPLCLas and scPLCL 
scaffolds.  
In hUC/hASC co-culture, both cell types remained viable on scPLCLas, whereas on 
plain scPLCL hASCs diminished. Myogenic phenotype of hASCs was also 
maintained in the co-culture on both scaffolds. Thus, AAD seems to be able to 
maintain hASCs in co-culture with used design. Co-culture medium still needs 
optimization, to be able to maintain good viability, proliferation capability and 
phenotype in both cell types.  
ScPLCLas scaffold appeared as promising scaffold for urethral tissue engineering 
applications, but some further optimizations for co-culture design should be 
considered. 
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